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[57) ABSI'RACT 
Quaternary pyridinium compounds, their use in inhibit-
ing acetylcholinesterase, their roles in the prophylaxis 
and treatment of organophosphate poisoning, their roles 
in anticholinesterase therapy and their roles as agents 
mimicking or opposing the actions of the natural neuro-
transmitter acetylcholine. 
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QUATERNARY PYRIDINIUM COMPOUNDS 
2 
Other approaches to OP antidotes have dealt with 
changes in the heteroaromatic ring system in order to 
improve the reactivation of OP-inhibited acetylcholin-
ST ATEMENT OF GOVERNMENT INTEREST esterase (Bedford, C. D., Harris, R. N., III., Howd, R. 
This invention was made with Government support s A., Goff, D. A., Koolpe, G. A., Petesch, M., Koplovitz, 
under Contract No. DAMD17-85-C-5143 awarded by I., Sultan, W. E., and Musallam, H. A., J. Med. Chem. 
the U.S. Army Medical Research and Development 1989, 32, 504; Bedford, C. D., Harris, R. N., Howd, R. 
Command. The Government has certain rights in the A., Goff, D. A., Koolpe, G. A., Petesc?, M., Miller, A., 
· fon Nolen, H. W., III., Musallam, H. A., Pick, R. 0., Jones, m~; is~ divisional of copending application Ser. No. 10 D. E., Koplovitz, I., and Sultan, W. E., J. Med. Chem. 
07/565,520 filed on Aug. 10, 1990. 1989, 32, 493! Benschop, H.P., Van der ~rg, G. R., 
Van der Hooidonk, C., DeJong, L. P.A., Kientz, C. E., 
BACKGROUND OF THE INVENTION Berends, F.; Kepner, L. A., Meeter, E., and Visser, R. 
1 Feld of the Invention P. L. S., J. Med. Chem. 1979, 22, 1306; Grifantini, M., Tru: invention relates to a novel class of quaternary lS M~lli, S., and Stein,_ M. L., J. Med. Chem. 1973, 16, 
pyridinium compounds useful for selectively inhibiting 937, mcorporated herem by reference). 
acetylcholinesterase (AChE) and to their use as nerve 
agent antidotes and prophylactics. We have found that 
certain quaternary pyridinium derivatives can offer in 20 
vivo protection against the nerve agents Soman (GD) 
and Tabun (GA) and therefore they can also offer pro-
tection against other organophophate poisons. We have 
also found that certain quaternary pyridinium deriva-
tives can effectively increase the rate of survival of 25 
experimental animals exposed to the nerve agents GD 
and GA and therefore they can also serve as antidotes 
against other organophosphate poisons. All of the ac-
tive pyridinium compounds are good AChE inhibitors 
in vitro and therefore they can also be used to treat 30 
conditions where a cholinergic deficit leading to pathol-
ogy can be ameliorated by administration of an anticho-
linesterase agent. All of the pyridinium compounds 
(lCH=NOH 
+I 
CH3 
2-PAM Chloride 
CH= NOH c N-:CH~r~N J-CONH, 
2c1-
HI-6 
described herein can have additional beneficial effects Since it is difficult to reactivate aged phosphonylated 
in living organisms by virtue of their resemblance to the 3S AChE, prophylatic treatment with AChE inhibitors 
natural neurotransmitter acetylcholine and their ability may be the preferred alternative. AChE is protected 
to act on cholinergic receptors. from nerve agents by preadministration of an AChE 
2. Description of the Related Art carbamylating agent such as pyridostigmine or physo-
Development of an effective antidote to organop~os- stigmine. These carbamates react covalently with 
phorus (OP) nerve agents has been a goal of medicinal 40 AChE at the active site serine, but the carbamylated 
chemists since the development of Tabun in Germany enzyme is hydrolyzed quickly to active enzyme (30 
in 1937. OP agents react covalently with the active site min.) while phosphonylated AChE requires several 
serine hydroxyl group of acetylcholinesterase (AChE) hours or days for regeneration of active AChE (Main, 
to form a stable phosphonyl ester which requires up to A. R., vide supra). Blocking AChE for a short period of 
30 days for hydrolysis (Main, A. R. In Biology of Cho/in- 4S time allows destruction of the OP agent by uncatalyzed 
ergic Function; Goldberg, A. M., Hanin, I., Eds.; Raven hydrolysis or reaction with enzymes such as carboxyles-
Press: New York, 1976; pp. 269-353, incorporated terase or pseudocholinesterase (Harris, L. W., Stitcher, 
herein by reference). Excess acetylcholine accumulates D. L., and Heyl, W. C., Life Sci 1980, 26, 1885, incorpo-
and causes severe neurological imbalance, respiratory rated herein by reference). Unfortunately, physostig-
paralysis, and death (Koelle, G. B. In The Pharmacologi- so mine is very toxic and small doses can be lethal. Fur-
ca/ Basis of Therapeutics; Goodman, L., and Gilman, A., thermore, physostigmine is unstable and would rapidly 
Eds.; MacMillan: New York, 1975; p. 404, incorporated decompose in the battlefield. Both carbamates are effec-
herein by reference). Pyridinium aldoximes (2-PAM tive only when combined with several other drugs 
and HI-6, see structures below) are currently used in (Heyl, W. C., Harris, L. W., and Stitcher, D. L., Drug 
conjunction with an acetylcholine antagonist (atropine) SS Chem. ToxicoL 1980, 3, 319, incorporated herein by 
· to reactivate the phosphonylated serine hydroxyl group reference). 
of AChE after poisoning occurs (Leadbeater, L., Inns, Other approaches to prophylaxis against OP poison-
R. H., and Rylands, J. M. Fund. App. ToxicoL 1985, 5, ing have involved the use of cyclic organophosphates to 
8225, incorporated herein by reference). This treatment temporarily block AChE (Ashani, Y., Leader, H., 
is ineffective against GD and GA because the initially 60 Raveh, L., Bruckstein, R. and Spiegelstein, M., J. Med. 
formed enzyme bound alkyl phosphonate esters un- Chem. 1983, 26, 14S, incorporated herein by reference), 
dergo rapid agiiig with loss of the alkoxy side chain to reduction of AChE levels by inhibition of choline ace-
form a negatively charged phosphonyl mono ester tyl transferase (Gray, A. P., Platz, R. D., Henderson, T. 
(Wolthuis, 0. L., Berends, F., and Meeter, E., Fund. R., Chang, T. C. P., Takahashi, K. and Dretchen, K. L., 
Appl ToxicoL 1981, 1, 183, incorporated herein by refer- 6S J. Med. Chem. 1988, 31, 807, incorporated herein by 
ence). The negative charge on this mono ester repels reference), and the use of antimuscarinic a-adrenergic 
nucleophiles which are required to dephosphonylate agonists (e.g., clonidine) to block the release of acetyl-
the enzyme. choline from presynaptic nerve terminals (Buccafusco, 
3 
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J. J. and Aronstam, R. S., J. Phannacol Exp. Ther. 1986, 
239, 43, incorporated herein by reference). 
Many oxime, semicarbazone, hydrazone and acyl 
hydrazone derivatives of2-formyl-3-hydroxy-1-methyl-
pyridinium chloride described herein incorporate both, s 
a nucleophile to displace the phosphonate from the 
serine hydroxyl group of AChE and an additional hy-
drogen bonding group (hydroxyl) to neutralize the neg-
ative charge on the aged phosphonate mono ester. In 
addition, the parent 3-hydroxypyridinium derivatives 10 
were converted into various carbamates since these are 
pyridostigmine analogs and can react covalently with 
AChE and thus provide protection from OP agents. 
DETAILED DESCRIPTION OF THE 
INVENTION 15 
Aldoxime, hydrazone, semicarbazone and acyl hy-
drazone derivatives of 2-formyl-1-substituted pyridin-
ium compounds are good inhibitors of acetylcholines-
terase (AChE) and can displace a nerve agent from the 20 
enzyme active site or protect the latter from attack by a 
nerve agent. Therefore these structures can be used as 
antidotes and prophylactics against nerve agents or 
other organophosphate poisons. Furthermore, it is pos-
sible that the carbamates act first as prophylactics 2s 
against OP poisoning and that the reaction products 
(3-hydroxy derivatives) act as reactivators of phos-
phonylated AChE (see below). Herein we describe one 
instance of this prophylactic/prodrug concept. 
30 
OCOCONR"R"' OCOH AChE > I ,.. 
N CH= Nu N CH=Nu 
+I +I 35 
R' R' 
Prophylactic 
Nu = nuclcophile 
Reactivator 
In addition to their AChE inhibitory properties, these 40 
derivatives can act on cholinergic receptors in the ner-
vous system either to mimic or to oppose the effects of 
the natural neurotransmitter acetylcholine. Therefore 
these structures can also be used in the treatment of 
conditions such as Myasthenia Gravis, Alzheimer's 45 
disease and adult Down's syndrome where a choliner-
gic deficit leading to pathology can be ameliorated by 
administration of a cholinomimetic or an anticholines-
terase agent. These structures can also act on the cardi-
ovascular system to produce an antihypertensive effect; SO 
they can be useful in the treatment of glaucoma; they 
can enhance bowel tone and motility. 
The novel substituted pyridinium derivatives have 
the following structural formulas: 
xll - md ,ax 
N CH=NOR1 B N CH=NOR1 
I+ I+ 
z z 
with any counterion to make pharmaceutically accept-
able salts, wherein 
SS 
60 
Z is selected from the group consisting of C1-6 alkyl, 65 
C1-6 alkyl with an attached phenyl group, Ct-6 
alkyl with an attached naphtyl group, C1-6 alkyl 
with two attached phenyl groups, C1-6 alkyl with 
an attached phenyl group mono, di, or trisubstitu-
ted with J, C1-6 alkyl with two attached phenyl 
groups mono, di, or trisubstituted with J, Ct-6 alkyl 
with an attached naphtyl group mono, di, or trisub-
stituted with J, 
wherein J is selected from the group consisting of 
halogen, COOH, OH, CN, N02, NH2, Ct-6 alkyl, 
Ct-6 alkoxy, C1-6 alkylamine, Ct-6 al-
kyl-O-CO-, C1-6 alkyl-O-:-CO-NH-, C1-6 
alkyl-NH-CO-NH-, C1-6 alkyl-N-
H-C0-0-, C1-6alkyl NH-CO-, (C1-6alkyl)-
2N-CO-, 
wherein X is selected from the group consisting of 
OH, C1-6 alkyl-NH-CO-O-, (C1-6 alkyl)-
2-N-CO-O-, · C1_; fluoroalkyl-N-
H-CO-O-, (C1-6 fluoroalkyl)2-N-
H-CO-O-, 
wherein R1 is selected from the group consisting of 
C1-6 alkyl, C1-6 alkyl with an attached phenyl 
group, C1-6alkyl with two attached phenyl groups, 
C1-6 alkyl with an attached phenyl group mono, di, 
or trisubstituted with K, C1-6 alkyl with two at-
tached phenyl groups mono, di, or trisubstituted 
with K, Ct-6 alkyl with an attached naphtyl group, 
C1-6 alkyl with an attached naphtyl group mono, 
di, or trisubstituted with K, C1-6 alkyl-T, 
wherein T is selected from the group consisting of 
formula (I) and formula (II), 
R' 
I+ 
-N-R" 
I 
R"' 
Formula I 
R' 
+I 
-N\ 
\.__ (CH:LJ3-8 
Formula II 
wherein R', R", and R"' are selected from the group 
consisting of H, C1-6 alkyl, C1-6 fluoroalkyl, C1-6 
alkyl with an attached phenyl group, C1-6 alkyl 
with an attached phenyl group mono, di, or trisub-
stituted with K, C1-6 fluoroalkyl with an attached 
phenyl group mono, di, or trisubstituted with K, 
wherein K is selected from the group consisting of 
halogen, COOH, OH, CN, N02, NH2, C1-6 alkyl, 
C1-6 alkoxy, C1-6 alkylamine, C1-6 al-
kyl-O-CO-, C1-6 alkyl-0-CO-NH-, C1-6 
alkyl-NH-CO-NH-, C1-6 alkyl-N-
H-C0-0-, C1-6alkyl NH-CO-, (C1-6alkyl)-
2N-CO-, 
wherein B is selected from the group consisting of H, 
C1-6alkyl. 
Alternatively the novel quaternary pyridinium com-
pounds are represented by the following structural for-
mulas: 
md 
5 
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-continued DX fl 
B N CH=NNH-C-NR2R3 
I+ 
z 
with any counterion to make pharmaceutically accept-
able salts, wherein 
Y is 0 or S, 
5 
10 
wherein Ri is selected from the group consisting of 
H, C1-6 alkyl, phenyl, C1-6 alkyl with an attached 
phenyl group, C1-6 alkyl with an attached phenyl 
group mono, di, or trisubstituted with K, C1-6alkyl 15 
with an attached naphtyl group, C1-6 alkyl with an 
attached naphtyl group mono, di, or trisubstituted 
with K, 
wherein R3 is selected from the group consisting of 
H, C1-6 alkyl, phenyl, C1-6 alkyl with an attached 20 
phenyl group, C1-6 alkyl with an attached phenyl 
group mono, di, or trisubstituted with K. 
Alternatively the novel quaternary pyridinium com-
pounds are represented by the following structural for-
mulas: 25 
X1~ 
~ ,l fl 
N CH=NNH-C-14 
I+ 
z 
and 
~X1 
h )l fl 
B N CH=NNH-C-14 
I+ 
z 
with any counterion to make pharmaceutically accept-
able salts, wherein 
X1 is selected from the group consisting of H, OH, 
30 
35 
40 
C1-6 alkyl-NH-C0-0-, (C1-6 alkyl)- 45 2-N-CO-O-, C1-6 fluoroalkyl-N-
H-C0-0-, (C1-6 fluoroalkyl)2-N-
H-CO-O-, 
wherein R4 is selected from the group consisting of 
C1-6 alkyl with a pyridinium ring attached through 50 
nitrogen, C1-6 alkyl with a pyridinium ring at-
tached through nitrogen and mono, di, or trisubsti-
tuted with K, C1-6 alkyl with a quinolinium ring 
attached through nitrogen and mono, di, or trisub-
stituted with K, C1-6 alkyl with an isoquinolinium 
ring attached through nitrogen and mono, di, or 55 
trisubstituted with K, C1-6 alkyl-T, 
alkyl with an attached phenyl group, C1-6 alkyl 
with an attached phenyl group mono, di, or trisub-
stituted with K, C1-6 fluoroalkyl with an attached 
phenyl group mono, di, or trisubstituted with K, 
wherein K is selected from the group consisting of 
halogen, COOR, OH, CN, N02, NHi, C1-6 alkyl, 
C1-6 alkoxy, C1-6 alkylamine, C1-6 al-
kyl-0-CO-, C1-6 alkyl-0-CO-NH-, C1-6 
alkyl-NH-CO-NH-, C1-6 alkyl-N-
H-C0-0-, Ct-6alkyl NH-CO-, (C1-6alkyl)-
2N-CO-. 
Alternatively the novel quaternary pyridinium com-
pounds are represented by the following structural for-
mulas: 
and 
t):x 
B N+ CH=NNRsll6 
I 
z 
with any counterion to make pharmaceutically accept-
able salts, wherein 
Rs is selected from the group consisting of C1-6 alkyl, 
phenyl, C1-6 alkyl with an attached phenyl group, 
C1-6 alkyl with an attached phenyl group mono, di, 
or trisubstituted with K, Ct-6 alkyl with an at-
tached naphtyl group, C1-6 alkyl with an attached 
naphtyl group mono, di, or trisubstituted with K, 
wherein Rt; is selected from the group consisting of 
H, Ct-6 alkyl, phenyl, C1-6 alkyl with an attached 
phenyl group, C1-6 alkyl with an attached phenyl 
group mono, di, or trisubstituted with K. 
Alternatively the novel quaternary pyridinium com-
pounds are represented by the following structural for-
mulas: 
xll Dx 
"" N 
1 
CH=NOH and B "" N 
1 
CH=NOH 
I+ I+ 
z z 
with any counterion to make pharmaceutically accept-
able salts. · 
wherein T is selected from the group consisting of 
formula (I) and formula (II), Alternatively the novel quaternary pyridinium com-pounds are represented by the following structural for-
60 mula: 
R' 
I+ 
-N-R" 
I 
R"' 
Formula I 
R' 
+I 
-N\ 
\__ (CH2h-s 
Formula II 
wherein R', R", and R"' are selected from the group 
consisting of H, C1-6 alkyl, C1-6 fluoroalkyl, C1-6 
65 n fl N CH=NNH-C-NR7Rg 
I+ 
z 
7 
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with any counterion to make pharmaceutically accept- 0-(2-Methyl-1-naphtylmethyl)-N-(1,6-dimethyl-3-
able salts, wherein hydroxy-2-pyridinemethylene) hydroxylamine chlo-
R 1 is selected from the group consisting ofC1-6alkyl, ride. 
phenyl, C1-6 alkyl with an attached phenyl group, O-Methyl-N-(3-hydroxy-1-methyl-2-pyridinemethy-
C1-6alkyl with an attached phenyl group mono, di, S lene) hydroxylamine chloride (le). 
or trisubstituted with K, C1-6 alkyl with an at- O-Methyl-N-(l,6-dimethyl-3-hydroxy-2-
tached naphtyl group, C1-6 alkyl with an attached pyridinemethylene) hydroxylamine chloride. 
naphtyl group mono, di, or trisubstituted with K, 0-[2-(1-Methyl-l-piperidinium]ethyl]-N-(3-hydroxy-1-
-CO-C1-6 alkyl, -CO-CJ-6 alkyl with an at- methyl-2-pyridinemethylene) hydroxylamine dichlo-
tached phenyl group mono, di, or trisubstituted lO ride. 
with K, 0-[2-(Trimethylammonium)ethyl]-N-(3-hydroxy-1-
wherein Rs is selected from the group consisting of methyl-2-pyridinemethylene) hydroxylamine dichlo-
H, C1-6 alkyl, phenyl, C1-6 alkyl with an attached ride. 
phenyl group, C1-6 alkyl with an attached phenyl lS O-(p-Chlorobenzyl)-N-(3-hydroxy-1-methyl-2-
group mono, di, or trisubstituted with K. . pyridinemethylene) hydroxylamine chloride (ld). 
Alternatively the novel quaternary pyridinium com- O-(p-Cyanobenzyl)-N-(3-hydroxy-1-methyl-2-
pounds are represented by the following structural for- pyridinemethylene) hydroxylamine chloride. 
mula: 0-(2-Hydroxy-4-nitrobenzyl)-N-(3-hydroxy-1-methyl-
ll N CH=NOR9 
I+ 
z 
20 2-pyridinemethylene) hydroxylamine chloride. 
O-(p-Carboxybenzyl)-N-(3-hydroxy-l-methyl-2-
pyridinemethylene) hydroxylamine chloride. 
O-(p-Chlorobenzyl)-N-(l,6-dimethyl-3-hydroxy-2-
pyriainemethylene) hydroxylamine chloride. 
2s O-(p-Cyanobenzyl)-N-(l,6-dimethyl-3-hydroxy-2-
pyridinemethylene) hydroxylamine chloride. 
0-(2-Hydroxy-4-nitrobenzyl)-N-(l,6-dimethyl-3-
with any counterion to make pharmaceutically accept- hydroxy-2-pyridinemethylene) hydroxylamine chlo-
able salts, wherein ride. 
R9 is selected from the group consisting of C1-6 alkyl 30 O-(p-Methoxybenzyl)-N-(3-hydroxy-1-methyl-2-
with an attached phenyl group, C1-6 alkyl with two pyridinemethylene) hydroxylamine chloride (le). 
attached phenyl groups, C1-6 alkyl with attached 0-(p-Dimethylaminocarbonyloxy benzyl)-N-(3-
phenyl group mono, di, or trisubstituted with K, C1-6 hydroxy-1-methyl-2-pyridinemethylene) hydroxy-
alkyl with two attached phenyl groups mono, di, or lamine chloride. 
trisubstituted with K, C1-6 alkyl with an attached naph- 3S 0-(p-Propylaminocarbonyl benzyl)-N-(3-hydroxy-1-
tyl group, C1-6 alkyl with an attached naphtyl group methyl-2-pyridinemethylene) hydroxylamine chlo-
mono, di, or trisubstituted with K. ride. 
The following compounds are representative of the 0-(p-Ethoxycarbonyl benzyl)-N-(3-hydroxy-1-methyl-
invention: 2-pyridinemethylene) hydroxylamine chloride. 
O-Benzyl-N-(l-methyl-2-pyridinemethylene) hydroxy- 40 O-(p-Methoxybenzyl)-N-(l,6-dimethyl-3-hydroxy-2-
lamine chloride (la). pyridinemethylene) hydroxylamine chloride. 
O-(Diphenylmethyl)-N-(l-methyl-2-pyridinemethy- 0-(p-Dimethylaminocarbonyloxy benzyl)-N-(1,6-
lene) hydroxylamine chloride. dimethyl-3-hydroxy-2-pyridinemethylene) hydroxy-
0-(p-Chlorobenzyl)-N-(1-methyl-2-pyridinemethylene) !amine chloride. 
hydroxylamine chloride. 4s 0-(p-Propylaminocarbonyl benzyl)-N-(l,6-dimethyl-3-
0-(p-Methoxybenzyl)-N-(1-methyl-2-pyridinemethy- hydroxy-2-pyridinemethylene) hydroxylamine chlo-
lene) hydroxylamine chloride. ride. 
0-(1-Naphtylmethyl)-N-(l-methyl-2-pyridinemethy- O-Benzyl-N-[3-(N',N'-dimethylcarbamoyl)hydroxy-1-
lene) hydroxylamine chloride. 50 methyl-2-pyridinemethylene] hydroxylamine chlo-0-(2-Methyl-l-naphtylmethyl)-N-(1-methyl-2- ride (2a). 
pyridinemethylene) hydroxylamine chloride. 0-[2-(1-Methyl-1-piperidinium)ethyl]-N-[3-(N',N'-
0-(2,3,4-Trimethoxybenzyl)-N-(1-methyl-2- dimethylcarbamoyl)hydroxy-1-methyl-2-
pyridinemethylene) hydroxylamine chloride. pyridinemethylene] hydroxylamine dichloride. 
0-(3,3-Diphenylpropyl)-N-(1-methyl-2-pyridinemethy- SS 0-[2-(Trimethylammonium)ethyl]-N-[3-(N',N'-dime-
lene) hydroxylamine chloride. thylcarbamoyl)hydroxy-1-methyl-2-pyridinemethy-
O-Benzyl-N-(3-hydroxy-1-methyl-2-pyridinemethy- lene] hydroxylamine dichloride. 
Jene) hydroxylamine chloride (lb). O-Benzyl-N-[3-(N',N'-diethylcarbamoyl)hydroxy-1-
0-(1-Naphtylmethyl)-N-(3-hydroxy-1-methyl-2- methyl-2-pyridinemethylene] hydroxylamine chlo-
pyridinemethylene) hydroxylamine chloride. 60 ride. . 
0-(2-Methyl-1-naphtylmethyl)-N-(3-hydroxy-l-meth- O-Benzyl-N-[3-(N',N'-difluoroethylcarbamoyl)hy-
yl-2-pyridinemethylene) hydroxylamine chloride. droxy-1-methyl-2-pyridinemethylene] hydroxylam-
0-(2,3,4-Trimethoxybenzyl)-N-(3-hydroxy-f-methyl-2- inc chloride .. 
pyridinemethylene) hydroxylamine chloride. O-Diphenylmethyl-N-(3-hydroxy-1-methyl-2-
0-(3,3-Diphenylpropyl)-N-(3-hydroxy-1-methyl-2- 6S pyridinemethylene) hydroxylamine iodide. 
pyridinemethylene) hydroxylamine chloride. O-Benzyl-N-[3-(N',N'-dimethylcarbamoyl)hydroxy-
0-(1-Naphtylmethyl)-N-(1,6-dimethyl-3-hydroxy-2- 1,6-dimethyl-2-pyridinemethylene] hydroxylamine 
pyridinemethylene) hydroxylamine chloride. chloride. 
9 
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0-Benzyl-N-[3-(N' ,N' -diethylcarbamoyl)hydroxy-1,6- 0-(2-Methyl-l-naphtylmethyl)-N-(5-hydroxy-1-meth-
dimethyl-2-pyridinemethylene] hydroxylamine chlo- yl-2-pyridinemethylene) hydroxylamine chloride. 
ride. 0-(2,3,4-Trimethoxybenzyl)-N-(5-hydroxy-1-methyl-2-
0-Benzyl-N-[3-(N' ,N' -difluoroethylcarbamoyl)hy- pyridinemethylene) hydroxylamine chloride. 
droxy-1,6-dimethyl-2-pyridinemethylene] hydroxy- 5 0-(3,3-Diphenylpropyl)-N-(5-hydroxy-1-methyl-2-
lamine chloride. pyridinemethylene) hydroxylamine chloride. 
0-(Diphenylmethyl)-N-[3-(N' ,N' -dimethylcarbamoyl)- O-Methyl-N-(5-hydroxy-1-methyl-2-pyridinemethy-
hydroxy- l-methyl-2-pyridinemethylene] hydroxy- lene) hydroxylamine chloride. 
lamine chloride (2b). O-(p-Chlorobenzyl)-N-(5-hydroxy-1-methyl-2-
0-(Diphenylmethyl)-N-[3-(N'-isopropylcarbamoyl)hy- 10 pyridinemethylene) hydroxylamine chloride. 
droxy-1-methyl-2-pyridinemethylene] hydroxy lam- O-(p-Chlorobenzyl)-N-( 5-hydroxy-1-methyl-2-
ine chloride. pyridinemethylene) hydroxylamine chloride. 
0-(Diphenylmethyl)-N-[3-[N' -(2-fluoroethyl)car- 0-(2-Hydroxy-4-nitro benzyl)-N-( 5-hydroxy-1-methyl-
bamoyl]bydroxy-1-methyl-2-pyridinemethylene] by- 2-pyridinemethylene) hydroxylamine chloride. 
droxylamine chloride. 15 0-(p-Carboxy benzyl)-N-(5-hydroxy-1-methyl-2-
0-(Diphenylmethyl)-N-[3-(N',N'-dimethylcarbamoyl)- pyridinemetbylene) hydroxylamine chloride. 
bydroxy-1,6-dimethyl-2-pyridinemethylene] bydrox- O-(p-Methoxybenzyl)-N-( 5-hydroxy-l-methyl-2-
ylamine chloride. pyridinemethylene) hydroxylamine chloride. 
O-(Diphenylmethyl)-N-[l,6-dimethyl-3-(N'-isopropyl- 0-(p-Dimethylaminocarbonyloxy benzyl)-N-(5-
carbamoyl)hydroxy-2-pyridinemethylene] hydroxy- 20 hydroxy-l-methyl-2-pyridinemethylene) hydroxy-
lamine chloride. lamine chloride. 
0-(Diphenylmetbyl)-N-[3-[N' -(2-fluoroethyl)car- 0-(p-Propylaminocarbonyl benzyl)-N-(5-hydroxy- l-
bamoyl]hydroxy-1,6-dimethyl-2-pyridinemethylene] methvl-2-pyridinemethylene) hydroxylamine chlo-
hydroxylamine chloride. ride. 
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- 25 0-(p-Ethoxycarbonyl benzyl)-N-(5-hydroxy-1-methyl-
bamoyl)hydroxy-1-methyl-2-pyridinemethylene] by- 2-pyridinemethylene) hydroxylamine chloride. 
droxylamine chloride (2c ). 0-Benzyl-N-[ 5-(N' ,N' -dimethylcarbamoyl)hydroxy-1-
0-(p-Methoxybenzyl)-N-[3-(N' ,N'-dimethylcar- methyl-2-pyridinemethylene] hydroxylamine chlo-
bamoyl)hydroxy-l-ethyl-2-pyridinemethylene] by- ride. . 
droxylamine chloride. 30 O-Benzyl-N-[5-(N',N'-diethylcarbamoyl)hydroxy-1-
0-(p-Methoxybenzyl)-N-([3-(M' ,N' -dimethylcar- methyl-2-pyridinemethylene] hydroxylamine chlo-
bamoyl)hydroxy- l-benzyl-2-pyridinemethylene] by- ride. 
droxylamine bromide. 0-Benzyl-N-[5-(N' ,N' -difluoretbylcarbamoyl)hydroxy-
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- l-methyl-2-pyridinemethylene] hydroxylamine chlo-
bamoyl)hydroxy-1,6-dimethyl-2-pyridinemethylene] 35 ride. 
hydroxylamine chloride. 0-(Dipbenylmethyl)-N-[ 5-(N' -isopropylcarbamoyl)hy-
0-(p-Metboxy.benzyl)-N-[3-(N' ,N' -dimethylcar- droxy-1-methyl-2-pyridinemethylene] hydroxylam-
bamoyl)hydroxy-l-ethyl-6-methyl-2-pyridinemethy- inc chloride. 
lene] hydroxylamine chloride. 0-(Dipbenylmethyl)-N-[5-[N' -(2-fluoroethyl)car-
O-(p-Methoxybenzyl)-N-[3-(N',N'-dimethylcar- 40 bamoyl]hydroxy-1-metbyl-2-pyridinemethylene] hy-
bamoyl)hydroxy-1-benzyl-6-methyl-2- droxylamine chloride. 
pyridinemethylene] hydroxylamine bromide. 0-(p-Methoxybenzyl)-N-[5-(N' ,N' -dimethylcar-
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- bamoyl)hydroxy- l-methyl-2-pyridinemethylene] hy-
bamoyl)hydroxy-1-(1-napbtylmethyl)-2- droxylamine chloride. 
pyridinemethylene] hydroxylamine chloride. 4S O-(p-Methoxybenzyl)-N-[5-(N',N'-dimethylcar-
0-(p-Methoxybenzyl)-N-[3-(N',N'-dimethylcar- bamoyl)hydroxy-1-ethyl-2-pyridinemethylene] hy-
bamoyl)hydroxy-1-(2-methyl-1-naphtylmethyl)-2- droxylamine chloride. 
pyridinemethylene] hydroxylamine chloride. 0-(p-Methoxybenzyl)-N-[5-(N' ,N' -dimetbylcar-
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- bamoyl)hydroxy-l-benzyl-2-pyridinemethylene] hy-
bamoyl)hydroxy-1-diphenylmethyl-2- SO droxylamine bromide. 
pyridinemethylene] hydroxylamine chloride. O-(p-Methoxybenzyl)-N-[5-(N',N'-dimethylcar-
0-(p-Methoxybenzyl)-N-[3-(N',N'-dimethylcar- bamoyl)hydroxy-1-(1-naphtylmethyl)-2-
bamoyl)hydroxy-l-(2-hydroxy-4-nitro benzyl)-2- pyridinemethylene] hydroxylamine chloride. 
pyridinemethylene] hydroxylamine chloride. 0-(p-Methoxybenzyl)-N-[5-(N' ,N' -dimethylcar-
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- SS bamoyl)hydroxy-1-(2-methyl-1-naphthylmethyl)-2-
bamoyl)hydroxy-1-(p-carboxy benzyl)-2- pyridinemethylene] hydroxylamine chloride. 
pyridinemethylene] bydroxylamine chloride. 0-(p-Methoxybenzyl)-N-[5-(N' ,N' -dimethylcar-
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- bamoyl)bydroxy- l-diphenylmethyl-2-
bamoyl)hydroxy-1-(p-cyanobenzyl)-2- pyridinemethylene] hydroxylamine chloride. 
pyridinemethylene] hydroxylamine chloride. 60 0-(p-Methoxybenzyl)-N-[5-(N',N'-dimethylcar-
N-[5-(N' ,N' -Dimethylcarbamoyl)hydroxy-l-methyl-2- bamoyl)hydroxy-1-(2-hydroxy-4-nitro benzyl)-2-
pyridinemethylene] hydroxylamine chloride (2d). pyridinemethylene] hydroxylamine chloride. 
N-(3-(N' ,N' -Dimethylcarbamoyl)hydroxy-l-methyl-2- 0-(p-Methoxybenzyl)-N-[5-(N' ,N' -dimethylcar-
pyridinemethylene] hydroxylamine chloride. bamoyl)hydroxy-1-(p-carboxy benzyl)-2-
N-[3-(N' ,N' -Dimethylcarbamoyl)hydroxy-1,6-dimeth- 65 pyridinemethylene] hydroxylamine chloride. 
yl-2-pyridinemethylene] hydroxylamine chloride. O-(p-Methoxybenzyl)-N-[5-(N',N'-dimethylcar-
0-(1-Naphtylmethyl)-N-(5-hydroxy-l-methyl-2- bamoyl)hydroxy-1-(p-cyanobenzyl)-2-
pyridinemethylene) hydroxylamine chloride. pyridinemethylene] hydroxylamine chloride. 
11 
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O-Benzyl-N-(l-benzyl-3-hydroxy-2-pyridinemethy- S-Hydroxy-1-methyl-2-[[(N-phenylaminothiocar-
lene) hydroxylamine bromide. bonyl)hydrazono]methyl] pyridinium chloride. 
O-Benzyl-N-(l-benzyl-S-hydroxy-2-pyridinemethy- 2-[[(N ,N-Diphenylaminocarbonyl)hydrazono ]methyl]-
lene) hydroxylamine bromide. S-hydroxy-1-methyl pyridinium chloride. 
2-[[(Aminocarbonyl)hydrazono]methyl]-3-hydroxy-1- S 2-[[(N,N-Dimethylaminothiocarbonyl)hydrazono]me-
methyl pyridinium chloride (3a). thyl]-S-hydroxy-1-methyl pyridinium chloride. 
2[[(Aminocarbonyl)hydrazono ]methyl]-S-hydroxy-1- 2-[[(N-Ethylaminothiocarbonyl)hydrazono ]methyl]-S-
methyl pyridinium chloride. hydroxy-I-methyl pyridinium chloride. 
2-[[(Aminothiocarbonyl)hydrazono ]methyl]-3- S-Hydroxy-1-methyl-2-[[(N-naphtylaminocarbonyl)hy-
hydroxy-1-methyl pyridinium chloride. 10 drazono]methyl]pyridinium chloride. 
2-[[(Aminothiocarbonyl)hydrazono]methyl]-S- 2-[[[N-(l-Chloro-2-naphtyl)amino carbonyl]hy-
hydroxy-1-methyl pyridinium chloride. drazono]methyl]-S-hydroxy-1-methyl pyridinium 
2-Hydrazonomethyl-3-hydroxy-1-methyl pyridinium chloride. 
chloride. 1-Methyl-2-CC~:p~enyl~ocarbonyl)hydrazono]-
2-Hydrazonomethyl-3-hydroxy-1 6-dimethyl pyridin- lS methyl] pyndinium chlonde (3d). 
ium chloride ' 2-[[(~ocarbonyl)hydrazono]methyl]-3-(N,N-dime-
2-Hydrazonom~thyl-S-hydroxy-l-methyl pyridinium ~ylcarbamoyl)hydroxy-1-methyl pyridinium chlo-
chloride. nde (~a). . 
1-Methyl-2-(3-hydroxy-1-methyl-2-pyridinemethylene) 2-[~~~~n)t):dr~:'J:et:tlt3-(N,N:::e-
hydrazine chloride. 20 Y ~ amoy Y oxy- • e Y pyn um 
2 chlonde. 1-Me~~l-1-phenyl-2-(3-hydr~xy-1-met?yl- - 2-[[(Aminocarbon l)h drazono]meth l]-S-(N N-dime-pyndmemethylene) hydrazme chlonde. y y y · · .' bl 
11 D. h 12-(3 h d 1 th 12 "din th thylcarbamoyl)hydroxy-1-methyl pyndinium c o-' - ip eny - - y roxy- -me y - -pyn eme y- "d 
lene) ~Y_drazine chloride. 2s 3~,~-Dimethylcarbamoyl)hydroxy-1-methyl-2-[[(N-l-(2,4:~1Dltrophenyl)-2-(3-hy~roxy-1-I?ethyl-2- phenylaminocarbonyl) hydrazono]methyl] pyridin-
pyndmemethylene) hydrazme chlonde. ium chlo "de (4b) 
1-Naphtyl-2-(3:hydroxy: 1-methyl-2-pyridinemethy- S-(N,N-rn:ethyl~bamoyl)hydroxy-1-methyl-2-[[(N-
lene) hydrazme chlonde. phenylaminocarbonyl) hydrazono]methyl] pyridin-
l-Methyl-2-(S-hydroxy-l-methyl-2-pyridinemethylene) 30 ium chloride. 
hydrazine chloride. 2-(3-Hydroxy-1-methyl-2-pyridinemethylene)-1-[2-(1-
1-Met~~l-l-phenyl-2-(S-hydr~xy-1-met?yl-2- pyridinium)acetyl] hydrazine dichloride (Sa). 
pyndmemethylene) hydrazme chlonde. 2-(1 6-Dimethyl-3-hydroxy-2-pyridinemethylene)-1-[2-
l, 1-Diphenyl-2~S-hydr~xy-1-methyl-2-pyridinemethy- d-pyridinium)acetyl] hydrazine dichloride. 
lene) hydrazme chlonde. JS 2-(S-Hydroxy-l-methyl-2-pyridinemethylene)-l-[2-(l-
l-(2,4:~initrophenyl)-2-(S-hy~roxy-l-I?ethyl-2- pyridinium)acetyl] hydrazine dichloride. 
pyndmemethylene) hydrazme chlon~e: 2-(3-Hydroxy-l-methyl-2-pyridinemethylene )-l-[2-
l-Naphtyl-2-(S:hydroxy: l-methyl-2-pyndmemethy- (trimethylammonium)acetyl] hydrazine dichloride. 
lene) hydrazme. chlonde. . . 1-[2-( 4-Chloro-l-pyridinium)acetyl]-2-(3-hydroxy-l-
l-Methyl-2-(l ,~imeth~l-3-hydroxy-2-pyndinemethy- 40 methyl-2-pyridinemethylene) hydrazine dichloride. 
lene) hydrazme chlonde: 2-(l,6-Dimethyl-3-hydroxy-2-pyridinemethylene)-1-[2-
1-Methyl-1-phenyl-2-(1,6-dimethyl-3-hydroxy-2- (trimethylammonium)acetyl] hydrazine dichloride. 
pyridinemethylene) hydrazine chloride. 2-(1,6-Dimethyl-3-hydroxy-2-pyridinemethylene )-1-[2-
l, 1-Diphenyl-2-(1,6-dimethyl-3-hydroxy-2- (4-chloro-1-pyridinium)acetyl] hydrazine dichloride. 
pyridinemethylene) hydrazine chloride. 4S l-[2-(3-Carboxy-l-isoquinolinium)acetyl]-2-(3-hydroxy-
3-Hydroxy-l-methyl-2-[[(N-phenylaminocarbonyl)hy- l-methyl-2-pyridinemethylene) hydrazine dichloride. 
drazono]methyl] pyridinium chloride (3b). l-[2-(2-Carboxy-4-methoxy-l-quinolinium) acetyl]-2-(3-
1,6-Dimethyl-3-hydroxy-2-[[(N-phenylaminocarbonyl)- hydroxy-l-methyl-2-pyridinemethylene) hydrazine 
hydrazono]methyl] pyridinium chloride. dichloride. 
S-Hydroxy-1-methyl-2-[[(N-phenylaminocarbonyl)hy- so 2-(3-Hydroxy-l-methyl-2-pyridinemethylene )-l-[2-(3-
drazono ]methyl] pyridinium chloride. · hydroxy-1-pyridinium)acetyl] hydrazine dichloride. 
3-Hydroxy-1-methyl-2-[[(N-phenylaminothiocar- 2-(3-Hydroxy-l-methyl-2-pyridinemethylene)-1-[2-(l-
bonyl)hydrazono ]methyl] pyridinium chloride. methyl-1-piperidinium)acetyl] hydrazine dichloride. 
2-[[(N,N-Diphenylaminocarbonyl)hydrazono ]methyl]- 2-(S-Hydroxy-1-methyl-2-pyridinemethylene)- l-[2-
3-hydroxy-l-methyl pyridinium chloride. SS (trimethylammonium)acetyl] hydrazine dichloride. 
1,6-Dimethyl-3-hydroxy-2-[[(N-phenylaminothiocar- 1-[2-( 4-Chloro-l-pyridinium)acetyl]-2-(S-hydroxy-1-
bonyl)hydrazono]methyl] pyridinium chloride. methyl-2-pyridinemethylene) hydrazine dichloride. 
1,6-Dimethyl-2-[[(N,N-diphenylaminocarbonyl)hy- 1-[2-(3-Carboxy-l-isoquinolinium)acetyl]-2-(S-hydroxy-
drazono]methyl]-3-hydroxy pyridinium chloride. l-methyl-2-pyridinemethylene) hydrazine dichloride. 
2-[[(N,N-Dimethylaminothiocarbonyl)hydrazono ]me- 60 1-[2-(2-Carboxy-4-methoxy-l-quinolinium)acetyl]-2-(S-
thyl]3-hydroxy-1-methyl pyridinium chloride. hydroxy-1-methyl-2-pyridinemethylene) hydrazine 
2-[[(N-Ethylamln.othiocarbonyl)hydrazono]methyl]-3- dichloride. 
hydroxy- I-methyl pyridinium chloride. 2-(S-Hydroxy-lmethyl-2-pyridinemethylene )-1-[2-(3-
3-Hydroxy-1-methyl-2-[[(N-naphtylaminocarbonyl)hy- hydroxy-1-pyridinium)acetyl] hydrazine dichloride. 
drazono ]methyl] pyridinium chloride. 65 2-(S-Hydroxy-l-methyl-2-pyridinemethylene )- l-[2-(1-
2-[[[N-(1-Chloro-2-naphtyl)amino carbonyl]hy- methyl-1-piperidinium)acetyl] hydrazine dichloride. 
drazono ]methyl]-3-hydroxy-1-methyl pyridinium 2-(1-Methyl-2-pyridinemethylene )-1-[2-(l-pyridinium-
chloride. )acetyl] hydrazine dichloride (Sb). 0-Benzyl-N-(l,6-
13 
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dimethyl-3-hydroxy-2-pyridinemethylene) hydroxy- values of 10 and 20 µM with electric eel and human 
lam.inc chloride. erythrocyte AChE, respectively. However, 3-hydroxy 
It has been found that the novel pyridinium com- substitution did not have the same effect on acyl hydra-
pounds of this invention are good acetylcholinesterase zones as with the aldoximes. In this case a 3-hydroxy 
inhibitors in vitro as shown in Tables I and II. The S group improved the binding to AChE. The complex 
pyridinium compounds also have good activity in vivo kinetics of Sb indicate at least two different binding 
as prophylactics and antidotes against nerve agent poi- modes for this inhibitor. At concentrations up to 7S µM, 
soning as shown in Tables III-VI. Sb acts as a noncompetitive inhibitor. However, at 
Competitive Inhibition of Acetylcholinesterase. The higher concentrations, Sb is an uncompetitive inhibitor. 
reversible inhibition studies on electric eel and human 10 Only noncompetitive kinetics were observed for Sa. 
erythrocyte AChE were performed at 2s· ± 1° C. in pH All of the semicarbazones (3a,b, 4b) also exhibited 
7.6, 0.lM phosphate buffer containing 4% ethanol using noncompetitive kinetics. In addition, multiple binding 
S-acetyl thiocholine as a substrate (Ellman, G. L., was observed and compound 3b had two distinct K1 
Courtney, D., Andres, V., and Featherstone, R. M., values of 30 µM and 340 µM with electric eel AChE. 
Biochem. PharmacoL 1961, 7, 88). For analysis of AChE 15 Addition of a phenyl group to give the semicarbazone 
inhibitory potency, electric eel AChE was dissolved in 3b resulted in a decrease of the ICsoto 240 µM with the 
buffer. Human erythrocyte AChE was dissolved in a human enzyme. From the kinetic results, it appears that 
O.OlM borate buffer (pH 10.2) containing 0.01 % prote- binding in a hydrophobic pocket near the active site is 
ase free bovine scrum albumin. S,S'-Dithiobis(2- the most important interaction for the semicarbazones. 
nitrobcnzoic acid) (DTNB) and S-acetylthiocholine 20 Compound 4b is the most indicative of this trend. Un-
were prepared in phosphate buffer. All inhibitor solu- like all other carbamates, it is not a time dependent 
tions were also dissolved in phosphate buffer; some inhibitor indicating that its position near the active site 
required the addition of 9S% ethanol. Increasing absor- serine is not equivalent to that occupied by the aldox-
bance during substrate hydrolysis was monitored on a imes 2a-c in the E.1 complex. Also, the 3-hydroxyl 
Varian DMS-90 spectrometer. Duplicate studies were 25 group does not negatively influence binding as with the 
performed on separate days using fresh solutions. No 3-hydroxy aldoximes which further indicates that bind-
time dependent inhibition was observed over a period ing of the semicarbazones is different from the aldox-
of at least one hour. Using three different substrate imes. 
concentrations and four inhibitor concentrations, a Irreversible Inhibition of Acetylcholinesterase. The 
Dixon plot (I/activity vs. inhibitor cone.) was made 30 irreversible inhibition studies of electric eel and human 
and the K1values determined. The K1value is the disso- erythrocyte AChE were performed at 2S 0 ±1 • C. in 
ciation constant of the enzyme-inhibitor complex. In- 0.lM phosphate buffer. Inhibitor and enzyme were 
hibitors with lower K1 values are more potent. In the incubated in a buffer solution of 1.0 mL total volume 
case of poor inhibitors an ICso was detemined by plot- and 100 µL aliquots were taken at 1 min intervals. The 
ting AChE activity vs inhibitor concentration. Only 35 aliquots were added to freshly prepared assay solutions 
values between 10% and 90% inhibition were used. The containing 20 µL of S-acetylthiocholine, 100 µL of 
exact procedure is as follows. DTNB, and 2280 µL of buffer. Increasing absorbance 
First, 20 µL of S-acetylthiocholine (0.07SM) and 100 was monitored at 412 nm. Pseudo first order inhibition 
µL of DTNB (0.10 M) were mixed together with phos- constants were determined by measuring the enzymatic 
phate buffer. Inhibitor was then added and the solution 40 activity of acetylcholinesterase after incubating the 
mixed well. Next, SO µL of electric eel AChE (1.5 enzyme with inhibitor for various time periods. Second 
units/mL) was added and the solution mixed again. order inhibition rate constants k«,sl[I] are reported in 
With human enzyme, 20 µL of a 2 units/mL stock solu- Table II. Inhibitors with higher k«isl[I] values are more 
tion was added. Increasing absorbance was monitored potent. Half-lives for inactivation ranged from 10.8 min 
at 412 nm. Controls were used for each run in the case 45 for 4a to about 9 sec for 2c. The k«,sl[I] for 2c was 
of inhibitors that absorb highly at 412 nm. Hydrolysis estimated at > 110,000M-ls-I because its rapit inacti-
rates of all inhibitors were negligible. Total volume and vation of AChE made it difficult to accurately deter-
organic solvent, if any, was kept constant. mine its inhibitory potency. Compounds 2a-c are novel 
Aldoximes (la,b,d,e) showed pure competitive inhibi- analogs of 2-PAM that also incorporate a dimethylcar-
tion of AChE whereas the semicarbazones (3a,b, 4b) SO bamyl substituent that reacts covalently with AChE. 
and acyl hydrazones (Sa, Sb) showed mixed-type inhibi- Compounds 2a and 2c have greater anti AChE activity 
tion of AChE (linear, noncompetitive). Results are sum- in vitro with human AChE than either pyridostigmine 
marized in Table I. or physostigmine. A notable selectivity for the human 
The 3-hydroxy substituted aldoximes did not inhibit enzyme was observed for all of the carbamates. The 
. either enzyme well, but did show some selectivity for SS scmicarbazone 4a inactivated AChE very slowly. In 
the electric eel enzyme. The 3-hydroxy derivative of contrast, the phenyl substituted semicarbazone carba-
2-P AM was also tested and did not inhibit either en- mate 4b was not a time dependent inhibitor of AChE 
zyme at concentrations up to 1 mM. Addition of a ben- over a period of 1.5 hours, unlike all other carbamates 
zyl group to the aldoxime of 3-hydroxy-2-PAM (lb) tested. Both compounds have similar K1 values with 
improves binding and lb has an ICso of 500 µM with 60 electric eel AChE; 4a has a K1of 100 µMand 4b has a 
electric eel AChE. The methylaldoxime le did not K1of 8S µM. A KJfor the human enzyme could not be 
inhibit either enzyme at concentrations up to 1 mM. determined for 4a because of its rapid inactivation of 
Without the 3-hydroxy substituent, tighter binding oc- AChE at inhibitor concentrations exceeding 10 times 
curs and K1values of 40 µMand 100 µM were observed the enzyme concentration. 
with eel and human enzymes respectively for the bcnzyl 65 Animal Studies-Pretreatment Activity. All animal 
aldoxime la. studies were carried out at Battelle, Inc., in Columbus, 
The bis-pyridinium acyl hydrazones Sa-b were the Ohio. The results of in vivo mouse evaluations against 
tightest binding reversible inhibitors with Sa having K1 GD for the compounds tested as intramuscular (i.m.) or 
15 
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oral pretreatment agents are given in Tables III and IV Oximes la-lfand semicarbazones 3b, 3c and 3d were 
respectively and were obtained as follows. Male ICR inactive in the i.m. pretreatment a8say. In the case of 
mice from Charles River (20 to 30 g average weight) substituted oxime derivatives a 3-hydroxy substituent 
were treated with three different doses of the pyridin- significantly reduces drug toxicity (la> lb). On the 
ium test compound i.m. lS or 60 min, or by gavage 30 or S other hand increasing the steric bulk of the oxyimino 
120 min before challenge with a dose of 2 x LDso of GD substituent increases drug toxicity (1 b > 1 c ). 
(LDso=98 µg/kg without atropine, LDso= 130 µg/kg Animal Studies-Reactivator Activity. The results of 
with 11.2 mg/kg of atropine). The 24 h LDsoofthe test in vivo mouse evaluations ag~st GD and ~A ~or the 
compounds administered i.m. or orally were deter- compounds tested as OP rea~tivators are given m Ta-
mined using S-7 dose groups withs animals per dose. 10 bl~ V and VI and we:e obtained as follows. Male _ICR 
As a negative reference treatment, saline was adminis- nnce from Char~es River (~O .t~ 30 g average weight) 
tered instead of the test compound. As a positive con- were ~eated with the ~Y?dini~ test compound at 
trol for survival, pyridostigmine (0.1 mg/kg, i.m.; 0.82 three differe~t doses administered i.m. 10 seconds after 
mg/kg, orally) was administered to a separate group of c:hallenge ~th 2XLDso of GD or GA (aqueous solu-
animals. All pretreatment groups received atropine 15 tlon containing 0.9% NaCl). The test compound was 
sulfate (11.2 mg/kg) and 2-P AM (2S mg/kg) i.m. ex- always given simult;aneously witk atropine sulfate (11.2 
actly 10 seconds after GD challenge, using a total dose ~g/kg). As a negative reference treatment group, atro-
volume of o.s mL/kg body weight. All animals were p~e s~ate (11.2 m~g~ ~d 2-P AM (2S mg/kg) w~re 
allocated to pretreatment cells in a randomized block give? without the p~dinium test comP?und (no nnce 
design. Groups of ten mice were used in each experi- 20 SUIVIve). As a i><>:'i~ve contr?l for s~val, HI-6 (9.6 
ment and survivors in each group were noted after 24 h. mg/kg) was administered with a~opme ~a~ (~ 1.2 
The 24-hour survival of animals pretreated with each mg/kg) to. a. separat~ grou~ of animals. All tnJectlons 
d f th "dini test d ed were administered i.m. usmg a dose volume of O.S ~seh oh 24-e hpyn w;n al bsecomedpo~ hwas coi:iipar f mL/kg body weight. All animals were allocated to 
wit t e our sUIVIv o rv m t e negative re - 25 tr tm t ll · d mized bl k d · G f erence pretreatment group. A survival difference of at teea . en ce susedm a ~an ° h .oc tesignd .UIVIr~upsrs? 
· · · if · ed ffi f n nnce were m eac expenmen an s vo m 
least fo~ 15 reqwred to ident Y unpr?v e cacy. 0 each group were noted after 24 h. The 24-hour survival 
the candidate over that observed with the negative of animals injected with each dose of test compound 
reference pretreatment. was compared to the 24-hour survival observed in the 
Compounds 2a-d,. 4a-~, S~-b were exce~ent pre~reat- 30 negative reference treatment cell. A survival difference 
ment agents, affordmg significant prot~tion a~amst a of at least four is required to identify improved efficacy 
dose of 2 X LDso of GD. In all cases salme solution was of the candidate over that observed with the reference 
~~the baseline. ~tandard (all mice di~) and pyrido- treatment. An alternate procedure used on some com-
stignnne. as the ~itive control for sUIVIval (80-100% pounds was the adjunct efficacy test: the pyridinium test 
of the nnce SUIVIve). 35 compound was always given simultaneously with atro-
. Carbamate derivatives 2a-2d showed.70 to 90% sur- pine sulfate (11.2 mg/kg) and 2-PAM (2S mg/kg). The 
vi~al rates at selected doses. After lS mm .pretreat~ent rest of the procedure is as described above. 
with compound 2a, 2b, or 2d 90% . of nnce s~ve a Carbamate oxime derivatives 2a, 2b, semicarbazone 
challenge of2XLDsoofGD at comparable fractions of 3a, carbamate semicarbazone 4b and bis-pyridinium 
the LDso's for these compounds (1/SS LDso of 2a, 1n2 40 acyl hydrazones Sa and Sb showed significant activity 
LDso of 2b, 1/67 LDso of 2d). ?n the other hand, com- as GD reactivators (Table V). The last two also showed 
poun~. 2c afforded a 70% sUIVIv~ rate. under the same significant activity as GA reactivators (Table VI). 
conditions but at a 1/16,700 fraction of its LDso. Carba- 2-PAM was used as the baseline standard while the 
mate semicarbazones 4a and 4b_and the acyl hydrazones positive control used HI-6 as the reactivator. Carba-
Sa and Sb were also very good i.m. pretreatment agents. 45 mate oximes 2a and 2b afforded 50% and 70% survival 
Carbamate semicarbazone 4a was exceptionally good as rates respectively at a dose 1/16 of their LDso's. They 
a pretreatment agent. Acyl hydrazones Sa and Sb were were also the most toxic of the five derivatives that 
also excellent pretreatment agents but their effective showed activity as OP reactivators. The greater inhibi-
doses were much closer to their toxic doses than was tion of AChE displayed by 2a compared to 2b is 
the case with 4a. Except for 4a, all remaining pretreat- so matched by its greater toxicity. A 62 fold increase in 
ment agents were more effective when given lS min koo.sl[I] accompanied by a 44 fold increase in toxicity 
prior to Soman challenge. The decrease in efficacy at 60 indicates that in the case of irreversible inhibitors a 
min may be due to transformation of the drugs to inac- compromise must be reached between the degree of 
tive metabolites and/or clearance from the animal. It inhibition that affords protection from the OP agent and 
was most noticeable for acyl hydrazones Sa and Sb, ss that which prevents the enzyme from performing its 
which are doubly charged and can be excreted more physiological role. It is noteworthy that 2a and 2b must 
rapidly. All seven pretreatment agents offered compa- be acting as prodrugs of the actual OP reactivator since 
rable or better protection against GD than the positive they do not possess a nucleophile themselves that can 
control, pyridostigmine. displace the OP from the active site of AChE. In the 
Carbamate derivatives 2a-2c and carbamate semicar- 60 semicarbazone series, a 3-hydroxy substituent increases 
bazone 4b showi:d excellent activity in the oral pretreat- in vivo activity (3a> > 3c). Semicarbazone 3a afforded 
ment studies. They afforded 80-100 survival rates at 120 70% survival rate at 1/2S of its LDso when given 10 
min prior to nerve agent challenge while pyridostig- seconds after a challenge of 2XLDso of Soman. Semi-
mine alone allowed no survival. In contrast to its good carbazone 3a was also an excellent reactivator when 
activity in the i.m. studies, bis-pyridinium acyl hydra- 65 tested in the adjunct assay: it afforded 90% survival rate 
zone Sa was not good as an oral pretreatment agent. when administered along with 2-PAM (2S mg/kg) 10 
This may be due to fast clearance from the animal re- seconds after Soman challenge. This combination of 
quiring higher doses that approach the toxic dose. drugs was more effective than HI-6 in counteracting 
17 
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Soman intoxication. Carbamate scmicarbazone 4b af- For injection, the therapeutic amount of pyridinium 
forded SO% survival rate at 1/16 of its LDso when given compounds of the present invention will normally be in 
10 sec after a challenge of 2XLDso of Soman. Bis- the dosage range from 0.2 mg to 140 mg/kg of body 
pyridinium acyl hydrazone Sa was an excellent GP weight. Administration is made by intravenous, intra-
reactivator. It afforded 90% survival rate at a dose of73 S muscular or subcutaneous injection. Accordingly, phar-
mmol/kg (approx. i LDso) when given 10 seconds after maceutical compositions for parenteral administration 
Soman challenge. will contain in a single dosage form about 10 mg to 7 
Two hydroxy 2-P AM derivatives (lf, lg) were pre- gms of pyridinium compound of the present invention. 
pared and tested for comparison with 2-PAM and with In addition to the active ingredient, these pharmaceuti-
the other substituted oxime derivatives reported in this 10 cal compositions will usually contain a buffer, e.g. a 
study. The parent 2-PAM is not an effective reactivator phosphate buffer which keeps the pH in the range from 
against Soman due to rapid "aging" of the inhibited 3.S to 7 and also sodium chloride, mannitol or sorbitol 
AChE. Adding a hydroxy substituent to the 3 or S for adjusting the isotonic pressure. 
position of2-PAM resulted in no improvement in reac- A composition for topical application can be formu-
tivating ability concurrent, with a small increase in tox- lS lated as an aqueous solution, lotion, jelly or an oily 
icity. In addition, these derivatives were not signifi- solution or suspention. A composition in the form of an 
cantly better than 2-PAM in the pretreatment assay. aqueous solution is obtained by dissolving the pyridin-
The carbamate of S-hydroxy-2-PAM chloride, com- ium compounds of the present invention in aqueous 
pound 2d, incorporates the structural features of pyri- buffer solution of pH 4 to 8.S and if desired, adding a 
dostigm.ine and 2-PAM. It afforded 90% survival rate at 20 polymeric binder. An oily formulation for topical appli-
a dose 1/67 of its LDso when given lS or 60 minutes cation is obtained by suspending the pyridinium com-
prior to Soman challenge. pounds of the present invention in an oil, optionally 
Summary-Animal Studies. The in vivo activity de- with the addition of a swelling agent such as aluminium 
scribed herein for some of the novel pyridinium com- stearate and/or a surfactant. 
pounds of this invention can be summarized as follows: 25 Synthetic Methods. All common chemicals and sol-
eight compounds (2a-2d, 4a, 4b, Sa, Sb) were effective vents were reagent grade or better. The purity of each 
i.m. prophylactics against GD; four compounds (2a-2c, compound was checked by lH NMR, mass spectros-
4b) were effective oral prophylactics against GD; six copy, thin-layer chromatography (TLC), and elemental 
compounds (2a, 2b, 3a, 4b, Sa, Sb) were good in vivo analysis. Results are consistent with the proposed struc-
reactivators against GD; two compounds (Sa, Sb) were 30 tures. Melting points were obtained on a Buehl capillary 
good in vivo reactivators against GA; five compounds melting point apparatus and are uncorrected. lH NMR 
(2a, 2b, 4b, Sa, Sb) were both excellent prophylactics spectra were recorded with a Varian Gemini 300 MHz 
and good reactivators against GD. Compounds 4a and NMR spectrometer; chemical shifts are reported in 
3a form a set in which an excellent prophylactic (4a) is parts per million (8) from an internal tetramethylsilane 
transformed by AChE into a good OP reactivator (3a). 3S standard. Mass spectra were recorded on a Varian Mat 
Structural requirements for prophylactic activity are a l 12s spectrometer. Elemental analyses were performed 
carbamate moiety and/or a second quaternary center. by Atlantic Microlab in Atlanta, GA. 3-Hydroxy-2-
Since carbamates may act as prodrugs for the actual pyridine carboxaldehyde (Stempel, A. and Buzzi, E. C., 
reactivators (i.e. 3a and 4a), the latter structural require- J. Am. Chem. Soc. 1949, 71, 2969; Ginsburg, S. and 
ments also apply for AChE reactivators in addition to 40 Wilson, I. B., J. Am. Chem. Soc. 19S7, 79, 481, incorpo-
scm.icarbazones having a free OH group in the pyridine rated herein by reference) was prepared from 3-
ring. hydroxy-2-hydroxymethyl pyridine by oxidation using 
Drug Delivery. For the prophylaxis of OP poisoning manganese dioxide (Demerseman, P., Kiffer, D., De-
and for the treatment of OP overdose, Myasthenia Gra- bussche, L., Lion, C., Royer, R., and S.-Roumanou, H., 
vis, senile dementia such as is seen in Alzheimer's and 4S Eur. J. Med. Chem. 1988, 23, 63, incorporated herein by 
adult Down's syndrome patients, high blood pressure, reference). Girard's reagent "P" [1-(carboxymethyl)-
glaucoma, and abdominal distension the pyridinium pyridinium chloride], 4-phenylsemicarbazide, and 3-
compounds of the present invention may be adm.inis- hydroxy-6-methyl-2-pyridinemetbanol were purchased 
tered orally, topically or parenterally. The term paren- from Aldrich Chemical Company. 
teral as used includes subcutaneous injection, intrave- SO The oxime, hydrazone, scm.icarbazone and acyl hy-
nous, intramuscular, intrasternal injection or infusion drazone derivatives described herein were prepared 
techniques. The dosage depends primarily on the spe- using standard methodology. Many different 0-sub-
cific formulation and on the object of the therapy or stituted hydroxylam.ines can be prepared by known 
prophylaxis. The amount of the individual doses as well procedures (Grochowski, E. and Jurczak, J., Synthesis 
as the administration is best determined by individually SS 1976, 682; Schumann, E. L., Heinzelman, R. V., Greig, 
assessing the particular case. M. E., and Veldkamp, W., J. Med. Chem. 1964, 7, 329, 
The pharmaceutical compositions containing the ac- incorporated herein by reference) to afford the various 
tive ingredient may be in a form suitable for oral use, for substituted oximes described herein. Several substituted 
example as tablets, troches, lozenges, aqueous or oily hydrazines are commercially available (i.e. methylhy-
suspensions, dispersible powders or granules, emulsions, 60 drazine, 1,1-dimethylhydrazine, 1,1-diphenylhydrazine, 
bard or soft capsules or syrups or elixirs. Dosage levels from Aldrich Chemical Co.) and others can be synthe-
ofthe order to 0.2 mg to 140 mg per kilogram of body sized by standard methodology (i.e. Hoffman degrada-
weight per day are useful in the treatment of above- tion of ureas, reduction of N-nitroso compounds, reduc-
indicated conditions (10 mg to 7 gms per patient per tion of diazonium salts) to afford the hydrazone deriva-
day). The amount of active ingredient that may be com- 6S tives described herein. Several substituted scm.icarba-
bined with carrier materials to produce a single dosage zides are commercially available (i.e. 4-phenyl-3-thi-
form will vary depending upon the host treated and the oscm.icarbazide, 4,4-diphenylsemicarbazide, 4,4-dimeth-
particular mode of administration. yl-3-thiosemicarbazide, 4-ethyl-3-thiosemicarbazide) 
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and others can be synthesized by standard methodology 3H), S.38 (s, 2H), 7.36-7.49 (m, SH), 8.09 (t, lH), 8.36 (d, 
(reduction of N-nitro ureas). Commercially available lH), 8.SS (t, lH), 8.84 (s, lH), 9.00 (d, lH). 
Girard's reagent "T" [(carboxymethyl) trimethylammo- O-Benzyl-N-(l-methyl-2-pyridinemethylene) hy-
nium chloride hydrazide] can be used instead of Gir- droxylamine chloride. Silver chloride (freshly prepared 
ard's reagent "P" to obtain 2-(trimethylammonium)a- S from 14.6 g AgN03 and excess cone. HCl) was added to 
cetyl hydrazine derivatives similar to Sa and Sb. Other a solution of 16.2 g (O.OS mol) ofO-Benzyl-N-(1-methyl-
hydrazides for the synthesis of various acyl hydrazones 2-pyridinemethylene)hydroxylamine iodide in 800 mL 
described herein can be made by known methodology HiO. The suspension was vigorously stirred with a 
(Vogel, A. I., in A Textbook of Practical Organic Chemis- mechanical stirrer for 4 h at room temperature. The 
try; Longman Group Limited:London. 1972; pp. 10 yellow precipitate was filtered off and the filtrate was 
976-978, incorporated herein by reference), which in- concentrated to dryness and coevaporated several times 
volves the reaction between an amine and ethyl chloro- with acetone. Traces of solvent are removed by evapo-
acetate, followed by reaction with hydrazine hydrate. ration at 5(1° C. in a rotary evaporator at 0.8 mm Hg 
Conversion of the 3 or S-hydroxy moiety into a carba- overnight. The yellow solid that remains (11.63 g) is 
mate was accomplished using N,N-dimethylcarbamyl lS recrystallized from EtOH/acetone with scratching to 
chloride. Other N,N-disubstituted carbamates can be obtain 8.1 g (68%) of analytically pure product as beige 
made by reaction between commercially available tri- microscopic needles; m.p. 14S0 -6° C. (dee.). Anal. 
phosgene and a disubstituted amine, followed by reac- Calcd. for C1"111sClN20XH20: C, 61.87; H, S.93; N, 
tion with the 3 or S-hydroxy pyridine derivative. N- 10.31; Cl, 13.0S. Found: C, 61.94; H, S.94; N, 10.31; Cl, 
monosubstituted carbamates can be prepared by reac- 20 13.10. lH NMR (Me2SO-d(;) 6: 4.38 (s, 3H), S.38 (s, 2H), 
tion of the free 3-0H group on the pyridine ring and any 7.36-7.48 (m, SH), 8.09 (t, lH), 8.3S (d, lH), 8.SS (t, lH), 
of numerous isocyanates that are commercially avail- 8.86 (s, lH), 9.08 (d, lH). 
able. In the case offluorinated derivatives, the synthesis O-(Diphenylmethyl)-N-(l-methyl-2-pyridinemethy-
of the appropriate fluoroalkylamine (some are commer- lene) hydroxylamine chloride 0-(p-chlorobenzyl)-N-(l-
cially available) is required, followed by reaction with 2S methyl-2-pyridinemethylene) hydroxylamine chloride 
phosgene to generate the desired isocyanate. Quaterni- 0-(p-methoxybenzyl)-N-(l-methyl-2-pyridinemethy-
zation of the pyridine nitrogen was carried out using lene) hydroxylamine chloride 0-(1-naphtylmethyl)-N-
methyl iodide in a sealed glass pressure vessel and was (l-methyl-2-pyridinemethylene) hydroxylamine chlo-
followed by anion exchange using a biphasic mixture of ride 0-(2-methyl-l-naphtylmethyl)-N-(l-methyl-2-
silver chloride and the methiodide in acetonitrile/wa- 30 pyridinemethylene) hydroxylamine chloride, 0-(2,3,4-
ter. Other salts of the pyridinium compounds described trimethoxybenzyl)-N-(l-methyl-2-pyridinemethylene) 
herein can be made in similar fashion, by methathesis hydroxylamine chloride, and 0-(3,3-diphenylpropyl)-
involving the silver salt of the desired counterion and N-(l-methyl-2-pyridinemethylene) hydroxylamine 
the methiodide formed in the initial alkylation of the chloride can be made by the same procedure replacing 
pyridine nitrogen. The usefulness of this procedure has 3s 0-benzyl hydroxylamine in the above example respec-
been studied with 2-PAM derivatives (Kondritzer, A. tively with 0-(diphenylmethyl) hydroxylamine, 0-(p-
A., Ellin, R. I., and Edberg, L. J., J. Phann. Sci. 1961, chlorobenzyl) hydroxylamine, 0-(p-methoxybenzy) 
SO, 109, incorporated herein by reference). hydroxylamine, 0-(1-naphtylmethyl) hydroxylamine, 
The following examples are given to illustrate the 0-(2-methyl-l-naphtylmethyl) hydroxylamine, 0-
invention and are not intended to limit it in any manner: 40 (2,3,4-trimethoxybenzyl) hydroxylamine, and 0-(3,3-
EXAMPLE 1 diphenylpropyl) hydroxylamine. 
Preparation of EXAMPLE2 
O-Benzyl-N-(l-methyl-2-pyridinemethylene) . Preparation of 
Hydroxylamine Chloride (la) 4s O-Benzyl-N-(3-hydroxy-l-methyl-2-pyridinemethy-
O-Benzyl-N-(2-pyridinemethylene) hydroxylamine. lene) hydroxylamine chloride (lb) 
0-Benzylhydroxylamine hydrochloride (12.77 g, 0.08 O-Benzyl-N-(3-hydroxy-2-pyridinemethylene) hy-
mol) was added to a solution ofNaOH (3.2 g, 0.08 mol) droxylamine. A solution of 0-benzyl hydroxylamine 
in 80 mL 1:1 EtOH/H20. Pyridine-2-carbaldehyde (7.6 so was prepared by dissolving 2 g of sodium hydroxide 
mL, 0.08 mol) was added to this solution and the result- (O.OS mol) and 8 g of 0-benzyl hydroxylamine hydro-
ing mixture was stirred at room temperature for 10 h. chloride (0.05 mol) in SO mL of SO% ethanol-water. To 
Excess water was removed under vacuum and the resi- this solution was added 6.15 g of 2-formyl-3-hydrox-
due was fractionally distilled under reduced pressure ypyridine (0.05 mol). The mixture was stirred for 3 h at 
(14 mm Hg). The product was obtained as a yellow oil SS room temperature. The precipitate was then filtered and 
in the fraction distilling at 85" -90" C. (11.3 g, 67% ). lH air dried to yield 10.3 g (90.3%) of pure product; m.p. 
NMR (MeiSO-d(;) 6: S.25 (s, 2H), 7.24 (t, lH), 7.32-7.44 64"-6S" C. lH NMR (CDCh) 6: 9.72 (s, lH, OH); 8.37 
(m, SH), 7.66 (t, lH), 7.78 (d, lH), 8.23 (s, lH), 8.58 (d, (s, lH, CH=N); 8.13 (d of d, J =2H, J =4 Hz, lH); 7.33 
lH). (m, 7H); S.17 (s, 2H, CH2). Anal. Calcd. for 
O-Benzyl-N-(1-methyl-2-pyridinemethylene)hydrox- 60 C13H12N202: C, 68.41; H, S.30; N, 12.27. Found: C, 
ylamine iodide .. Methyl iodide (14.3 mL, 0.23 mol) was 68.34; H, S.32; N, 12.21. 
added to a solution of O-Benzyl-N-(2-pyri9ffiemethy- 0-Benzyl-N-(3-hydroxy-1-methyl-2-pyridinemethy-
lene) hydroxylamine (11.3 g, 0.05 mol) in 7S mL of lene) hydroxylamine chloride. O-Benzyl-N-(3-hydroxy-
acetonitrile. The resulting mixture was heated in a pres- 2-pyridinemethylene) hydroxylamine (2.65 g, 11.6 
sure vessel at 6S° C. for 24 h. The solvent was removed 6S mmol) was placed in a pressure tube together with 7 g 
in vacuo and the residue was triturated with acetone to of methyl iodide and 40 mL of a 2:3 mixture of EtOH/-
afford the product as a light orange solid (17.2 g, 92%), water. The reaction mixture was heated at 6S° C. for 20 
m.p. 125•_7• C. (dee.). lH NMR (MeiSO-d6) 6: 4.36 (s, h and the solvent was then removed in vacuo. The 
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residue was triturated with acetone to afford 2.50 g 0.14 mol) was added to a solution of O-methyl-N-(3-
(58%) of product as greenish crystals; m.p. 247° C. hydroxy-2-pyridinemethylene) hydroxylamine (4.83 g, 
(dee.). The methiodide salt (4.90 g, 13.2 mmol) was 32 mmol) in 20 mL of acetonitrile. The reaction mixture 
dissolved in 22 mL of a 1:1 mixture of acetonitrile and was heated in a pressure glass bottle at 70° C. for 20 h 
water and freshly made AgCl was then added (from 4:0 S and then concentrated to dryness in vacuo. The result-
g AgN03 and excess cone. HCl, washed well with wa- ing yellow solid was triturated with acetone and filtered 
ter). Additional water (15 mL) was added to this sus- to yield 7.72 g (82%) of product which was used in the 
pension and the res~ting ~ture ~~ stirred at room next step without further purification. 
tempera~e for 40 mm. The silver iodide was removed O-Methyl-N-{3-hydroxy-1-methyl-2-pyridinemethy-
by ~tration and °:Je filtraU: was commcen1;fated to~- 10 lene) hydroxylamine chloride. The methiodide obtained 
ness m vacuo to ~eld a residue that was tritilrated ~th in the previous step (7.72 g 26 mmol) was dissolved in 
acetone. The solid that resulted was washed well with ' 
to d dried to · Id 3 61 (98,,,.) f od t 230 mL of HiO. Freshly made AgCl (7.6 g, 53 mmol) ace ne an yie . g -10 o pr uc as added this 1 · d th ul · · white crystals; m.p. 146• c. lH NMR (DMSO-di;) 8: was . IO so ution an e res ting suspens~on 
8.58 (d, lH, J =5.0 Hz), 8.55 (s, lH), 8.20 (d, lH, J = 7.3 lS w~ stirred at room temperature for 1.5 h. The react10n 
Hz), 7.90 (d of d, lH), 7.42 (m, SH), 5.34 (s, 2H), 4.27 (s, mixture ~as filtered and the .filtrat~ was concentrated to 
3H). Anal. Calcd. for Ci4HisN2o2c1xH2o: c, 56.65; dryness m vacuo. The white solid that resulted was 
H, 5.78; N, 9.43; Cl, 11.94. Found: c, 56.65; H, 5.79; N, triturated with warm (40° C.) acetone and filtered to 
9.40; Cl, 11.88. yield 4.35 g (83%) of product; m.p. 186°-1• C. (dee.). lH 
0-(1-Naphtylmethyl)-N-(3-hydroxy-1-methyl-2- 20 NMR (DMSO-di;) 8: 8.62 (d, lH, J=6.0 Hz); 8.48 (s, 
pyridinemethylene) hydroxylamine chloride, 0-(2- lH); 8.31 {d, lH, J=8.5 Hz); 7.93 (d of d, lH, J=6.0 Hz, 
methyl-1-naphtylmethyl)-N-(3-hydroxy-1-methyl-2- J =8.5 Hz). Anal. Calcd. for CsH11N2ClQi: C, 47.41; H, 
pyridinemethylene) hydroxylamine chloride, 0-(2,3,4- 5.47; N, 13.83; Cl, 17.50. Found: C, 47.47; H, 5.49; N, 
trimethoxybenzyl)-N-(3-hydroxy-1-methyl-2- 13.76; Cl, 17.43. 
pyridinemethylene) hydroxylamine chloride, and 0- 2s O-Methyl-N-(5-hydroxy-1-methyl-2-pyridinemethy-(3,3-diphenylpropyl)-N-(3-hydroxy-l-methyl-2- lene) hydroxylamine chloride can be made by the same 
pyridinemethylene) hydroxylamine chloride can be procedure replacing 3-hydroxy-2-pyridine aldehyde in 
made by the same procedure replacing 0-benzyl by- the above example with 2-formyl-5-hydroxy pyridine. 
droxylamine in the above example respectively with 0-[2-(1-Methyl-l-piperidinium]ethyl]-N-(3-hydroxy-1-
0-(l-naphtylmethyl) hydroxylamine, 0-(2-methyl-l- 30 methyl-2-pyridinemethylene) hydroxylamine dichlo-
naphtylmethyl) hyd~oxylamine, 0-(2,~,4-trimethoxy- ride and 0-[2-(trimethyl ammonium)ethyl]-N-(3-
benzyl) hy~roxylamme, and 0-(3,3-diphenylpropyl) hydroxy-l-methyl-2-pyridinemethylene) hydroxylam-
hydroxyl~e: O-(l-Naphtylmethyl)-N-(~-hydrox~-1- ine dichloride can be made by the same procedure re-
methyl-2-pyndmemethylene) hydroxylamme chlonde, placing methoxyamine in the above example with 0-[2-
0-(2-~~thyl-l-naphtylmethyl-N-(5-~ydroxy-l-~ethyl- 35 (l-piperidine)ethyl] hydroxylamine and 0-[2-(dime-
2-pyn~emethylene) hydroxylamine chlonde, 0- thylamino)ethyl] hydroxylamine. 
(2,3,4-tnmethoxybenzyl)-N-( 5-hydroxy-l-methyl-2-
pyridinemethylene) hydroxylamine chloride, and 0- EXAMPLE 4 
(3,3-diphenylpropyl)-N-(5-hydroxy-l-methyl-2-
pyridinemethylene) hydroxylamine chloride can be 40 
made by the same procedure substituting 3-hydroxy-2-
pyridine carbaldehyde for 2-formyl-5-hydroxy pyri-
dine. 
Preparation 
O-(p-Chlorobenzyl)-N-(3-hydroxy-l-methyl-2-
pyridinemethylene) hydroxylamine chloride (ld) 
0-(p-Chlorobenzyl)hydroxylamine hydrochloride. 
EXAMPLE3 
The hydroxylamine hydrochloride was prepared by 
4s hydrazinolysis of the corresponding benzyloxyphthali-Preparation of mide. The phthalimide (15 g, 0.051 mol) was dissolved 
O-Methyl-N-{3-hydroxy-1-methyl-2-pyridinemethy- in DMF (75 mL) and MeOH (260 mL) was warmed to 
lene) hydroxylamine chloride (le) 60° C. The solution was treated with hydrazine mono-
O-Methyl-N-(3-hydroxy-2-pyridinemethylene) by- hydrate (5.7 g, 0.11 mol) ~d allowed~ ".°°l to room 
droxylamine. NaOH (1.62 g, 0.04 mol) was added to a so te~perature for 3 h. The mixture was acidified to pH 2 
solution of methoxyamine hydrochloride (3.4 g, 0.04 wtth 2N HCl and filtered: The filtrate was evaporated 
mol) in 30 ml of H20. 3-Hydroxy-2-pyridine carboxal- ~ dryness and treated wtth 2~ NaOH (75 mL). The 
dehyde (5.0 g, 0.04 mol) was added to the clear solution, o~y product was extracted wtth e!11er, and ~e com-
followed by 15 mL ofEtOH. The reaction mixture was bmed ether extracts were washed wtth HiQ, dried over 
stirred at room temperature for 15 hand concentrated ss anhy~rous. K1C03, and C<?ncentrated in vacuo. The 
in yacuo to a minimum volume (approx. 5 mL). Water r~ulttng oil. ~as treated wtth ether~ hydr?gen chlo-
(15 mL) was added to this residue and the resulting nde to preeipitate the product as a white solid. Reerys-
solution was extracted with EtOAc (4X20 mL). The tallization from EtOH gave the pure hydroxylamine 
organic extract was dried (MgS04), filtered and con- hydrochloride as shiny white plates (9.5 g, 96%), m.p. 
centrated in high vacuum to a yellow oil that crystal- 60 235° C. [lit. m.p. 245• C.; Schumann, E. L., Heinzelman, 
1izes upons cooling in a bath of isopropanol-dry ice to R. V., Greig, M. E., and Veldkamp, W., J. Med. Chem. 
yield 4.83 g (79%) of product as a white solid; m.p. 1964, 7, 329]. 1H NMR (CDCIJ) d: 7.23(s, 4H); 5.00(s, 
186°-7° C. (dee). lH NMR (CDCl3) 8: 9.82 (s, lH); 8.35 2H). 
(s, lH); 8.21 (d of d, lH, J = 1.5 Hz, J =4.5 Hz); 7.30 (d 0-(p-Cyanobenzyl)hydroxylamine hydrochloride, 
of d, lH, J = 1.5 Hz, J =8.5 Hz); 7.19 (d of d, lH, J =4.5 6S 0-(2-Hydroxy-4-nitrobenzyl) hydroxylamine hydro-
Hz, J=8.5 Hz). chloride, and 0-(p-Carboxy benzyl)hydroxylamine hy-
0-Methyl-N-(3-hydroxy-1-methyl-2-pyridinemethy- drochloride can be made by the same procedure replac-
lene) hydroxylamine iodide. Methyl iodide (8.9 mL, ing p-chlorobenzyloxyphtalimide respectively with 
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p-cyanobenzyloxyphtalimide, 2-hydroxy-4-nitroben- pyridinemethylene) hydroxylamine chloride can be 
zyloxyphtalimide, and p-carboxybenzyl oxyphtalimide. made by the same procedure replacing 3-hydroxy-2-
0-(p-Chlorobenzyl)-N-(3-hydroxy-2-pyridinemethy- pyridine aldehyde with 2-formyl-5-hydroxy pyridine. 
lene) hydroxylamine. 0-(4-Chlorobenzyl) hydroxylam-
ine hydrochloride (9.75 g, 50 mmol) was neutralized 5 EXAMPLE 5 
with NaOH (2.0 g, 50 mmol dissolved in 20 mL H20). Preparation of 
Ethanol (20 mL) was added to solubilize the resulting O-(p-Methoxybenzyl)-N-(3-hydroxy-1-methyl-2-
hydroxylamine. 3-Hydroxy-2-pyridinealdehyde (6.2 g, pyridinemethylene) hydroxylamine chloride (le) 
50 mmol) dissolved in H20 (150 mL) was added and the 
mixture heated on a steam bath for 30 min. The solution 10 ~-~Methoxybenzyl)-N-(3-hy~oxy-2-
was cooled to room temperature. The product crystal- pyndinemethylC?e) hydroxylamme. 0-(p-metho~yben-
lized out as long pale yellow needles. The mixture was zyl) hydroxylamine (5.55 g, 29 IDlD;ol; Grochowski et al, 
filtered to isolate the pure product (12.5 g, 96%), m.p. 1976 and _Schumann et al, 1964, VIde sui:ira) was added 
89°-90° c. lH NMR(CDCh) 8: 9.67 (s, lH); 8_33 (s, to a solution of~a~H (1.2 g, 29 mmol) m 15 mL H20. 
lH); 7.33-7.13 (m, 1H); 5.17 (s, 2H). Anal. Calcd. for 15 3-Hydroxy-2-pyndine carbaldehyde (3.6 g, 29 mmol) 
C13H11N20 2Cl: C,59.43; H, 4.23; N,10.67; Cl, 13.49. was then added, followed by 15 mL of95% EtOH and 
Found: C, 59.43; H, 4.26; N, to.64; Cl, 13.56. 10 mL of acetone. The reaction mixture was stirred at 
O-(p-Chlorobenzyl)-N-(3-hydroxy-1-methyl-2- room tempera~e for 4 ~and v.:as then poured over~ 
pyridinemethylene) hydroxylamine iodide. A solution mL of crushc:ct ice. A_ beige solid comes out of solution 
of O-(p-chlorobenzyl)-N-(3-hydroxy-2-pyridinemethy- 20 upon scrat;ching the Sides ~fthe ~er. It was filtered, 
lene) hydroxylamine (1.0 g, 3.8 mmol) in EtOH (45 mL) washed with wa~r 8!1d dried to yield 7.03 g (93%) of 
was placed in a glass pressure tube. Methyl iodide (1 product; m.p. 79 -81 C. 1H NMR (CDCh) 8: 9.85 (s, 
mL, 16.0 mmol) was then added, and the tube was lH); 8.38 (s, lH); 8.19 (d of d, lH); 7.36 (d of d, 2H); 7.28 
sealed tightly. The tube was heated at 69° c. in an oil (d of d, lH); 7.18 (d of d, lH); 6.93 (d of d, 2H); 5.15 (s, 
bath for 20 h. The solution was concentrated in vacuo. 25 2H); 3.82 (s, 3H). 
·The oily residue was triturated with acetone to give the ~-9'-Methoxybenzyl)-N-(3-hy~oxy-1-m~thyl-2-
crude product as a yellow solid (1.46 g, 95%). Reerys- p~dmemethylene) hydroxylamme chlonde. ~ethyl 
tallization from acetone gave the pure product as a 1od1de (7.2 mL, 0.12 mol) was added to a solution of 
shiny yellow solid (0.8 g, 52%), m.p. 164°-166° c. lH O-(p-methoxy)benzyl-N-(3-hydroxy-2-pyridinemethy-
NMR (CDCl3/DMSO-d6) 8: 8.83-8.67 (m, 2H)· 30 lene) hydroxylamine (3.72 g, 14 mmol) in 60 mL of 
8.13-7.67 (m, 2H); 7.33 (s, 4H); 5.00 (s, 2H); 4.43 (s, 3H)'. acetonitrile. The resulting mixture was divided into 
Anal. Calcd. for C14H1~202CII: C, 41.55; H, 3.49; N, three pressure glass vessels and heated at 10• C. for 3 
6.92; Cl, 8.76; I, 31.36. Found: C, 41.62; H, 3.53; N, 6.92; days. The solvent was removed in vacuo and the resi-
Cl, 8.71; I, 31.28. due was triturated with ether/acetone (3:1); after dry-
0-(p-Chlorobenzyl)-N-(3-hydroxy-1-methyl-2- 35 ing, the methiodide weighed 4.88 g (85%). It was dis-
pyridinemethylene) hydroxylamine chloride. To a solu- solved in 500 mL H20 and 300 mL of acetonitrile and 
tion of the corresponding pyridinium iodide (1.0 g, 2.47 freshly made AgCl (2 eq.) was then added. The suspen-
mmol) in CH3CN1H20 (1:1, 15 mL) was added freshly sion was stirred at room temperature for 1.5 hand then 
made AgCl (from 0.54 g AgN03 and cone. HCl). The filtered through Celite. The filtrate was concentrated to 
mixture was allowed to stir at room temperature for 1.5 40 dryness in vacuo and the residue was triturated with 
h. It was then filtered through a bed of Celite. The acetone/ether (1:1). The yellow solid was filtered, 
solvent was removed in vacuo. Trituration of the resi- washed first with acetone/ether (1:1), then with ether 
due with acetone gave the pure ·pyridinium chloride and dried to yield 3.57 g (97%) of pure product, m.p. 
(0.72 g) in 93% yield, m.p. 175° C. (dee). IH NMR 183°-184° C. (dee.). lff NMR (d6-DMSO) 8: 8.57 (d, 
(CDCl3/DMSO-rl6) 8: 8.67 (m, lH); 8.37 (m, lH); 45 lH, J=6.l Hz); 8.50 (s, lH); 8.19 (d, lH, J=8.2 Hz); 
8.00-7.67 (m, lH); 7.37 (s, 4H); 5.3 (s, 2H); 4.33 (s, 3H). 7.88 (d of d, lH, J=6.l Hz, J=8.2 Hz); 7.38 (d, 2H, 
Anal. Calcd. for C14li1~202Cli; C, 53.68; H, 4.51; N, J=8.7 Hz); 6.95 (d, 2H, J=8.7 Hz); 5.25 (s, 2H); 4.26 (s, 
8.95; Cl, 22.64. Found: C, 53.76; H, 4.56; N, 8.92; Cl, 3H); 3.75 (s, 3H). Anal. Calcd. for C1sH1,ClN203X0.55 
22.57. H20: C, 6.53; H, 5.73; N, 8.79; Cl, 11.13. Found: C, 
O-(p-Cyanobenzyl)-N-(3-hydroxy-1-methyl-2- SO 56.53; H, 5.72; N, 8.79; Cl, 11.18. 
pyridinemethylene) hydroxylamine chloride, 0-(2- · O-(p-Dimethylaminocarbonyloxybenzyl)-N-(3-
hydroxy-4-nitrobenzyl)-N-(3-hydroxy-1-methyl-2- · hydroxy-1-methyl-2-pyridinemethylene) hydroxylam-
pyridinemetbylene) hydroxylamine chloride, and 0-(p- ine chloride, O-(p-propylaminocarbonylbenzyl)-N-(3-
carboxybenzyl)-N-(3-bydroxy-1-metbyl-2- hydroxy-1-methyl-2-pyridinemethylene) hydroxylam-
pyridinemetbylene) bydroxylamine chloride can be 55 ine chloride, and O~thoxycarbonyl benzyl)-N-(3-
made by the same procedure replacing 0-(p-chloroben- hydroxy-1-methyl-2-pyridinemethylene) hydroxylam-
zyl) hydroxylamine respectively with 0-(p-cyanoben- ine chloride can be made by the same procedure replac-
zyl)-N-(3-hydroxy-2-pyridinemethylene) hydroxylam- ing 0-(p-methoxybenzyl) hydroxylamine in the above 
ine, 0-(2-bydroxy-4-nitrobenzyl)-N-(3-bydroxy-2- example respectively with 0-(p-dimethylaminocar-
pyridinemethylene) hydroxylamine, and 0-(p-carbox- 60 bonyloxy . benzyl) hydroxylamine, O-(p-
ybenzyl)-N-(3-hydroxy-2-pyridinemethylene) hydroxy- propylaminocarbonyl benzyl) hydroxylamine, and 0-
lamine. O-(p-Chlorobenzyl)-N-(5-hydroxy-1-methyl-2- (p-ethoxycarbonyl benzyl) hydroxylamine. 0-(p-
pyridinemethylene) hydroxylamine chloride, 0-(p- Methoxybenzyl)-N-(5-hydroxy-l-methyl-2-
cyanobenzyl)-N-(5-bydroxy-1-metbyl-2- pyridinemethylene) hydroxylamine chloride, 0-(p-
pyridinemet~ylene) hydroxylamine chloride, 0-(2- 65 dimethylaminocarbonyloxy benzyl)-N-(5-hydroxy-1-
bydroxy-4-rutro benzyl)-N-(5-bydroxy-1-methyl-2- metbyl-2-pyridinemethylene) hydroxylamine chloride 
pyridinemethylene) hydroxylamine chloride, and 0-(p- 0-(p-propylaminocarbonyl benzyl)-N-(5-hydroxy-1: 
carboxy benzyl)-N-(5-hydroxy-1-metbyl-2- methyl-2-pyridinemetbylene) hydroxylamine chloride, 
25 
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and 0-(p-ethoxycarbonyl benzyl)-N-(5-hydroxy-1-
methyl-2-pyridinemethylene) hydroxylamine chloride 
can be made by the same procedure replacing 3-
hydroxy-2-pyridine aldehyde in the above example with 
2-formyl-5-hydroxy pyridine. 
EXAMPLE6 
carbamoyl) hydroxy-1-methyl-2-pyridinemethylene] 
hydroxylamine chloride, 0-benzyl-N-[5-(N' ,N'-diethyl-
carbamoyl)hydroxy-1-methyl-2-pyridinemethylene] 
hydroxylamine chloride and 0-benzyl-N-[5-(N',N'-
!I difluoroethylcarbamoyl)hydroxy-1-methyl-2-
pyridinemethylene] hydroxylamine chloride can be 
made by the same procedure replacing 3-hydroxy-2-
Preparation of pyridine aldehyde with 2-formyl-5-hydroxy pyridine. 
0-Benzyl-N-[3-(N' ,N' -dimethylcarbamoyl)hydroxy-1- 0-[2-(l-Methyl-1-piperidinium)ethyl]-N-[3-(N' ,N' -
methyl-2-pyridinemethylene] hydroxylamine chloride 10 dimethylcarbamoyl)hydroxy-1-methyl-2-
(2a) pyridinemethylene] hydroxylamine dichloride, and 0-
0-Benzyl-N-[3-{N',N'-dimethylcarbamoyl)hydroxy- [2-(trimethylammonium)ethyl]-N-[3-{N',N'-dimethyl-
2-pyridinemethylene] hydroxylamine. Dimethylcarba- carbamoyl)ltydroxy-1-methyl-2-pyridinemethylene] 
myl chloride (7 mL, 76 mmol) was added to a solution hydroxylamine dichloride can be made by the same 
of 2.59 g (11 mmol) of O-benzyl-N-(3-hydroxy-2- lS procedure replacing 0-benzylhydroxylamine in the 
pyridinemethylene] hydroxylamine (prepared as re- above example with 0-[2-(l-piperidine)ethyl] hydroxy-
ported on previous page) in 20 mL of pyridine. The lamine and 0-[2-(dimethylamino)ethyl] hydroxylamine. 
resulting mixture was stirred at 65" C. for 12 h and 
poured over 400 mL of ice water. The aqueous solution EXAMPLE 1 
was extracted with ether (6X50 mL); the ether layer 20 Preparation of 
was dried (Na2S04), filtered and concentrated to dry- 0-(Diphenylmethyl)-N-[3-{N',N'-dimethylcarbamoyl)-
ness to a yellow oil which was coevaporated with H20 hydroxy-1-methyl-2-pyridinemethylene] 
and with acetone to remove the remaining pyridine. hydroxylamine chloride (2b) 
The residue was dissolved in 10 mL acetone, and water O-(D' h Im th l)-N-(3 h dr 2 was added with cooling and stirring until no more pre- 2S • . 1P eny e Y - Y . oxy- - . 
cipitate came out of solution. The white solid was fil- pyndinemet~ylene] hydroxylamme. 0-Dipheny~ethyl 
tered, washed with water and dried to yield 3.02 g hydroxylamme (3.4 g, 14.4 mmo~; Grochowski et al, 
(89%) of product; m.p. 65"-66" c. lff NMR (CDClJ) 8: 1976 and .Schumann et al, 1964, vide supra) .was added 
8.54 (d of d, lH, J =4Hz,J=1 Hz); 8.38 (s, lH); 7.54 (d to a solution of NaOH ~o .. 58 g, 14.4 mmol) m 7 mL of 
ofd, lH, J=8.3 Hz, J=l.5 Hz); 7.30-7.43 (m, 6H); 5.30 30 water. 3-Hydroxy-2-pY_Odme ~baldehyde (1.~ g, 1~.4 
(s, 2H); 3.06 (s, 3H); 2.97 (s, 3H). mmol) was. added to this solution and the resulting ~-
0-Benzyl-N-[3-{N',N' -dimethylcarbamoyl)hydroxy- tur~ ~as stUTed a~ rooI? temperature for 4 h. The wh!-te 
1-methyl-2-pyridinemethylene] hydroxylamine iodide. solid m the reaction ~e w~ filtered, washed with 
A solution of 2.95 g (9.9 mmol) of O-benzyl-N-[3- H20/EtOH0(l:l~ and dned to yield 3.17 (72%) ofprod-(N',N'-dimethylcarbamoyl)hydroxy-2-pyridinemethy- 3S uct, m.p. 82 -83 C. 1H NMR (CDCIJ) 8: 9.60 (s, lH); 
lene] hydroxylamine and 2.8 mL (44 minol) of methyl 8.51 (s, lH); 8.2 (d of d, lH); 7.30-7.43 (m, lOH); 7.23 (d 
iodide in 20 mL of acetonitrile was heated at 65" C. in a of d, lH); 7.16 (d of d, lH); 6.29 (s, lH). 
glass pressure bottle for 2 days. The reaction mixture 0-(Diphenylmethyl)-N-[3-{N',N'-dimethylcar-
was concentrated to dryness to a dark orange oil which b~oyl)hydroxy-2-pyrid~emethylene] hydroxylamine. 
was triturated with cold acetone to yield a bright yel- 40 Dimethylcarbamyl chlonde (9 mL, 98 mmol) was 
low precipitate that was washed with acetone and added to a solution of O-(diphenylmethyl)-N-(3-
ether. After drying the product weighed 4.02 g (92%). hydroxy-2-pyridinemethylene] hydroxylamine (3.0 g, 
0-Benzyl-N-[3-(N',N'-dimethylcarbamoyl)hydroxy- 9.9 mmol) in 30 mL of pyridine. The resulting mixture 
l-methyl-2-pyridinemethylene] hydroxylamine chlo- was stirred at room temperature for 14 hand poured 
ride. The methiodide obtained in the previous step (4.02 4S over 400 mL of crushed ice. A white solid precipitates 
g, 9 mmol) was dissolved in 25 mL H20 and 20 mL upon scratching the sides of the beaker. It was filtered, 
acetonitrile. Freshly prepared AgCI (2.61 g, 18 mmol) washed thoroughly with water and dried to yield 3.47 g 
was added to this solution and the resulting suspension (94%) of product, m.p. 89°-90° C. lff NMlt. (d6-
was stirred at room temperature for 1 h. The reaction DMSO) 8: 8.49 (d of d, lH); 8.37 (s, lH); 7.64 (d of d, 
mixture was filtered and the filtrate was concentrated to so lH); 7.47 (d of d, lH); 7.42-7.28 (m, lOH); 6.29 {s, lH); 
dryness to a white solid that was triturated with warm 2.81 (s, 3H); 2.74 (s, 3H). 
(40" C.) acetone for 20 min and filtered. The white solid 0-(Diphenylmethyl)-N-[3-{N',N'-dimethylcar- . 
was washed with acetone and ether to yield 3.2 g ( quan- bamoyl)hydroxy-1-methyl-2-pyridinemethylene] hy-
titative) of the pure chloride, m.p. 150"-152" C. {dee.); droxylamine chloride. Methyl iodide (2.8 mL, 46 mmol) 
. lff NMR (DMSO-ci6) 8: 9.09 {d, J =5.5 Hz, lH); 8.74 (s, SS was added to a solution of 0-(diphenylmethyl)-N-[3-
lH); 8.59 {d, J=8.4 Hz, lH); 8.19(d of d, J=8.4 Hz, (N',N'-dimethylcarbamoyl)hydroxy-2-pyridinemethy-
J=5.5 Hz, lH); 7.42 (m, SH); 5.33 (s, 2H); 4.39 (s, 3H); lene] hydroxylamine (3.44 g, 9.2 mmol) in 40 mL of 
2.98 (s, 311); 2.92 (s, 3H). Anal. Calcd. for acetonitrile. The resulting mixture was divided into two 
C11HwClN303X0.45HiO: C, 57.04; H, 5.89; N, 11.74; pressure glass vessels and heated at 70" C. for 3 days. 
Cl, 9.91. Found: C, 56.99; H, 5.95; N, 11.69; Cl, 9.91. 60 The solvent was removed in vacuo and the residue (4.92 
0-Benzyl-N-[3-{N',N'-diethylcarbamoyl)hydroxy-1- g) was dissolved in a mixture of acetonitrile/water (200 
methyl-2-pyridinemethylene] hydroxylamine chloride mL:200 mL). Freshly made AgCl (2 eq, washed well 
and 0-benzyl-N-[3-{N',N'-difluoroethylcarbamoyl)hy- with H20) was added to this solution and the resulting 
droxy-l-methyl-2-pyridinemethylene] hydroxylamine suspension was stirred at room temperature for 2 h. It 
chloride can be made by the same procedure replacing 6S was filtered through Celite and the filtrate was concen-
N,N-dimethylcarbamoyl chloride respectively with trated to dryness in vacuo to a residue that was tritu-
N,N-diethylcarbamoyl chloride and N,N-difluoroethyl- rated with ether. The white solid was collected by fil-
carbamoyl chloride. 0-Benzyl-N-[5-(N',N'-dimethyl- tration and dried to yield 3.84 g (98%) of pure product, 
5,206,371 
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m.p. 153°-154° C. (dee.). lH NMR (d6-DMSO) 8: 9.06 H20: C, 55.59; H, 5.96; N, 10.Sl; Cl, 9.12. Found: C, 
(d, lH, J =6.0 Hz); S.S7 (s, lH); S.55 (d, lH, J =S.4 Hz); 55.59; H, 6.03; N, 10.76; Cl, 9.17. 
S.lS (d of d, lH, 1=6.0 Hz, J=S.4 Hz); 7.45-7.30 (m, 0-(p-Methoxybenzyl)-N-[3-(N',N'-dimethylcar-
lOH); 6.44 (s, lH); 4.35 (s, 3H); 2.S (s, 3H); 2.79 (s, 3H). bamoyl)hydroxy-l-ethyl-2-pyridinemethylene] hydrox-
Anal. Calcd. for C23H24ClN303X 1.19 H20: C, 61.76; S ylamine chloride, 0-(p-methoxybenzyl)-N-[3-(N',N'-
H, 5.94; N, 9.39; Cl, 7.93. Found: C, 61.76; H, 6.02; N, dimethylcarbamoyl)hydroxy-l-benzyl-2-
9.41; Cl, 7.97. pyridinemethylene] hydroxylamine bromide, O-(p-
0-(Diphenylmethyl)-N-[3-(N'-isopropylcarbamoyl)- methoxybenzyl)-N-[3-(N',N'-dimethylcarbamoyl)hy-
bydroxy-l-methyl-2-pyridinemetbylene] hydroxylam- droxy-1-(1-naphtylmethyl)-2-pyridinemethylene] hy-
ine chloride and O-(diphenylmethyl)-N-[3-[N'-(2- 10 droxylamine chloride, O-(p-methoxybenzyl)-N-[3-
fluoroetbyl)carbamoyl]hydroxy-l-methyl-2- (N' ,N' -dimethylcarbamoyl)bydroxy-1-(2-methyl-l-
pyridinemethylene] hydroxylamine chloride can be napbtylmethyl)-2-pyridinemethylene] hydroxylamine 
made by the same procedure replacing N,N-dimethyl- chloride, O-(p-methoxybenzyl)-N-[3-(N',N'-dimethyl-
carbamyl chloride respectively with isopropyl isocya- carbamoyl)hydroxy-l-dipbenylmethyl-2-
nate and 2-fluoroethyl isocyanate. 0-(Diphenylmethyl)- lS pyridinemethylene] hydroxylamine chloride, O-(p-
N-[5-(N'-isopropylcarbamoyl)hydroxy-l-methyl-2- methoxybenzyl)-N-[3-(N',N'-dimethylcarbamoyl)hy-
pyridinemethylene] hydroxylamine chloride and 0-(di- droxy-1-(2-bydroxy-4-nitrobenzyl)-2-pyridinemethy-
phenylmethyl)-N-[5-[N'-(2-fluoroethyl)carbamoyl]hy- lene] hydroxylamine chloride, O-(p-methoxybenzyl)-N-
droxy-l-methyl-2-pyridinemethylene] hydroxylamine [3-(N' ,N' -dimethylcarbamoyl)hydroxy-1-(p-carbox-
chloride can be made by the same procedure replacing 20 ybenzyl)-2-pyridinemethylene] hydroxylamine chlo-
3-hydroxy-2-pyridine aldehyde with 2-formyl-5- ride, and 0-(p-methoxybenzyl)-N-[3-(N',N'-dimethyl-
hydroxy pyridine. carbamoyl)hydroxy-l-(p-cyanobenzyl)-2-
EXAMPLES pyridinemethylene] hydroxylamine chloride can be made by the same procedure replacing methyl iodide in 
Preparation of 25 the above example respectively with ethyl iodide, ben-
0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- zyl bromide, 1-chloromethyl naphtalene, l-chlorometh-
bamoyl)hydroxy-l-methyl-2-pyridinemethylene] yl-2-methyl naphtalene, chlorodiphenylmethane, 2-
bydroxylamine chloride (2c) chloromethyl-4-nitrophenol, 4-chloromethyl benzoic 
O-(p-Methoxybenzyl)-N-[3-(N',N'-dimethylcar- 30 acid, and ~y~o. benzyl chloride. O-(p-Methoxyben-bamoyl)hydroxy-2-pyridine methylene] hydroxylam- zyl)-N-[~~ ,N -d1methylcarbamoyl)_hydroxy:l-meth-
ine. Dimethylcarbamyl chloride (10 mL, 0.11 mol) was yl-2-pyndmemethylene] ~y'!1"o~ylamme chlonde, 0-(p-
added to a solution of O-(p-methoxybenzyl)-N-(3- methoxybenzyl)-N-~5:CN ,N -dimethylcarbamoyl)hy-. 
hydroxy-2-pyridinemethylene) hydroxylamine (3.3 g, drox~-l-ethyl-2-pyndinemethylene] hy~o~ylamine 
12.S mmol) in 30 mL of pyridine. The resulting mixture JS chlonde, 0-(p-methoxybenzyl)-N~[~-(N ,N -dimethyl-
was stirred at room temperature for 14 h and then carbamo~l)hydrox~-l-benzyl-2-pyndinemethylene] h~-
poured over 400 mL of crushed ice. Since it was not m:oxylamme bromide, 0-(p-methoxybenzyl)-N-[5-(N, 
possible to induce precipitation of the product, the N :m;nethylcarbamoyl)hydroxy-l~l-naphty!methyl)-2-
aqueous mixture was extracted with ether (4X 100 mL) pyndmemethylene] by~ro~y~amme chlonde, 0-(p-
and the organic extract was concentrated to dryness in metboxybenzyl)-N-[5-(N ,N -dimethylcarbamoyl)hy-
vacuo. The oily residue was coevaporated with water 40 droxy-1-(2-methy~-l-naphtylmethyl)-2-pyridinemethy-
to remove traces of pyridine and then with acetone. The lene] h,yd~o~ylamme chlonde, O-(p-metho~ybenzyl)-N-
300 MHz lH NMR of the resulting yellow oil shows no [51 -<N ·~ ~ethylcarbamoy))hydroxr·l-diph~nylmeth-
pyridine or water and was used in the next step without yl-2-pyndmemethylene] hydroxylamme chlonde, 0-(p-
further purification. 4s methoxybenzyl)-N-[5-(N',N'-dimethylcarbamoyl)hy-0-(p-Methoxybenzyl)-N-[3-(N' ,N' -dimethylcar- droxy-1-(2-hydro~y-4-nitr~benzyl)-2-pyridinemethy-
bamoyl)bydroxy- l-methyl-2-pyridinemethylene] by- lene] ~y~~xylamine chlonde, 0-(p-methoxybenzyl)-N-
droxylamine chloride. Methyl iodide (2.9 mL, 46.4 [5-(N ,N -d1me~~lcarbamoyl)hydroxy-l~box-
mmol) was added to each of two pressure glass tubes y_benzyl)-2-pyndinemetbylene] bydr~xy~~e chlo-
containing a solution of 0-(p-methoxybenzyl)-N-[3- SO nde, 0-(p-methoxybenzyl)-N-[5-(N ,N :-d:imethylcar-
(N' ,N' -dimethylcarbamoyl)hydroxy-2-pyridinemethy- bamoyl)bydroxy- ~ -(p-cyan_?benzyl)-2-pyndinemethy-
lene] hydroxylamine (3.S2 g, 11.6 mmol, divided into lene] hydroxy~e chlonde can be~~ by the same 
two) in 40 mL of acetonitrile. The sealed reaction ves- p~occdure replacing 3-hyW:o~y-2-pyndine aldehyde 
sels were heated at 70" C. for 3 days and then the sol- with 2-formyl-5-hydroxy pyndine. 
vent was removed in vacuo. The resulting oil crystal- SS EXAMPLE 9 
lizes upon standing at o• -5· C. for 14 h in a 2:1 mixture 
of acetone/ether (75 mL). The yellow solid was fil-
tered, washed with ether and dried to yield 4.94 g 
(90%) of crude methiodide. It was dissolved in 1: 1 mix-
Preparation of 
N-(5-(N' ,N' -Dimethylcarbamoyl)hydroxy-l-methyl-2-
pyridine methylene] hydroxylamine chloride (2d). 
ture of H20/acetonitrile (200 mL) and then freshly (i() 2-Formyl-~·hydroxypyridine. To a stirred solution of 
made AgCI (21 mmol, washed well with water) was 21.8 g of 5-hydroxy-2-picoline (0.2 mol) in 200 mL of 
added. The resulting suspension was stirred at room glacial acetic acid was added 18 mL of 30% hydrogen 
temperature for 2 h and filtered through Celite. The peroxide (0.159 mol) in one portion. The mixture was 
filtrate was concentrated to dryness in vacuo and the heated in an oil bath at so• -85° C. with stirring for 3 h. 
residue was triturated with 1:1 acetone/ether. The 6S Then another lS mL of hydrogen peroxide was added 
white solid that resulted was filtered, washed with ether and the mixture was stirred for 3 h at the same tempera-
and dried to yield 3.72 g (S4.4%) of pure chloride, m.p. ture. Excess solvent was removed in vacuo followed by 
145°-6° C. (dee.). Anal. Calcd. for C1sH22ClN304X0.5 the addition of acetone, which caused the pyridine N-
29 
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oxide to crystallize. Without further purification, 200 (s, lH); 8.40 (d of d, 2H, J =2 Hz, 9 Hz); 4.36 (s, 3H); 3.3 
mL of acetic anhydride was added to the solid and the (s, H20); 3.1 (s, 3H); 2.95 (s, 3H). Anal. Calcd. for 
mixture was heated at 120° C. with stirring in an oil bath C1oH1~303Cl·H20: C, 43.25; H, 5.81; N, 15.13; Cl, 
for 2 h. After cooling to room temperature, exc:esS 12.76. Found: C, 43.42; H, 5.81; N, 15.09; Cl, 12.87. 
acetic anhydride was removed by high vacuum distilla- 5 N-[3-(N',N'-Dimethylcarbamoyl)hydroxy-1-methyl-
tion. The oily material was again oxidized with 30% 2-pyridinemethylene] hydroxylamine chloride can be 
hydrog~n peroxi~e twice and rearranged with acetic made by the same procedure replacing 2-formyl-5-
anhydnde followmg the same procedure and amounts hydroxypyridine with 3-hydroxy-2-pyridine carbalde-
depicted above. The black oily material obtained was hyde. 
- hydrolyzed with 200 mL of lN HCl (0.2 mol) at room 10 
temperature for 3 weeks (hydrolysis at higher tempera- EXAMPLE 10 
ture may be harmful to the pyridine nucleus). The mix- Preparation of 
ture was neutralized with anhydrous sodium carbonate, 2-[[(Amino~nyl)hydrazono]methyl]-3-hydroxy-1-
indicated by litmus paper and then extracted three times methyl pyridinium chloride (3a) 
with 300 mL of diethylether. The combined ether ex- 15 
tracts were dried (MgS04), filtered and evaporated to 2-[[(Aminocarbonyl)hydrazono]methyl]-3-hydroxy 
leave a solid material in a small amount of oil. The pure pyridin~. Sodium acetate (2.21 g, 16 mmol) was dis-
product (7.8 g, 32%) was obtained by filtering the solid, solved~ 25 mL of water and then semicarbazide hy-
followed by washing it with a small amount of ether. It drochlonde was_ 8?ded (1.81 g, 16 mmol), followed by 
is yellow in color and shows a sharp melting point at 20 3-hy~oxy-~-pyndine al~ehyde (2.0 g, 16 mmol). The 
186°-187° C. lH NMR (<16-DMSO) 8: 11 10 (br s, IH resulting mixture was stirred at room temperature for 2 
OH); 9.87 (s, lH, CHO); 8.35 (d, J=2 Hz: IH); 7.58 (d: h. The so~d in the reactio? mix~e was then filtered, 
J=9 Hz, IH); 7.35 (d ofd, J=2 Hz, 9 Hz, lH). washed_wtth water and dried t? yield 2.71 g (93'.3) of 
N-(5-Hydroxy-2-pyridinemethylene) hydroxylamine. the semicar~?e. It was~ m "!e next step without 
To 200 mL of 2.5% (w/w) sodium hydroxide solution 25' further p~cation; m.p.: 215 -217 C.(dec.). 
was dissolved 5.5 g of 5-hydroxy-2-formylpyridine (45 2-[[(Amin~"';><>nY!)h~drazono]methyl]-3-hydroxy-
mmol). Subsequently 12.5 g ofhydroxylamine HCl (180 1-~~thyl P~?inium iodide. A glass :pr~ure tube con-
mmol) was added to the solution in one portion. The taining a strrnng bar.was charged with 20 grams (11.1 
solution turned cloudy after being stirred for 10 min- mmoles) of. ~-[[(aminocarbo1:1yl)hydrazono]methyl]-3-
utes. After stirring at room temperature for 3 h, the 30 hydroxy pyndme~ 2.~ g of barium carbonate, 7.0 g (49.3 
precipitate was filtered under vacuum and dried in the mmol) of methyl 1od1de and 30 mL of DMF. The reac-
air for several days to yield 4.8 g of N-(5-hydroxy-2- tion mixture was stirred for two days at 65" C. in an oil 
pyridinemethylene) hydroxylamine (78%). The solid is bath. After that time the solvent was removed in vacuo, 
off white and decomposes at 195" C. IH NMR (d6- the residue shaken with 50 mL of warm water and 
DMS0)8: 11.27 (br. s, lH); 10.83 (br. s, IH); 8.18 (d, 35 filtered. The filtrate was then treated with an aqueous 
J=2 Hz, IH); 8.05 (s, IH, CH=N); 7.72 (d, J=9 Hz, solution of H2S04 in amount needed for the precipita-
lH); 7.25 (d ofd, J=2 Hz, 9 Hz, IH). tion of Ba2+ present in the solution. After collecting 
N-[5-(N',N'-Dimethylcarbamoyl)hydroxy-2-pyridine BaS04. the filtrate was concentrated and crystallized 
methylene] hydroxylamine. Dimethylcarbamoyl chlo- from a mixture of water and ethanol to afford 2.1 g 
ride (5.2 mL, 57 mmol) was added to a solution ofN-(5- .o40 (58.3%) of the methiodide salt, m.p. 180°-182° C. 
hydroxy-2-pyridinemethylene) hydroxylamine ( 6.53 g, 2-[[ (Aminocarbonyl)hydrazono ]methyl]-3-hydroxy-
47 mmol) in 40 mL of pyridine. It was stirred at room I-methyl pyridinium chloride. The preceeding iodide, 
temperature overnight and then the solvent was re- 6.0 grams (18.6 mmol) was dissolved in 150 mLofwater 
moved in vacuo, leaving a light green paste. The paste and stirred with silver chloride precipitated from a 
was dissolved in a minimum quantity of acetone and 45 solution of 6.0 g (35.3 mmol) of silver nitrate with ex-
then triturated with ethyl acetate and placed in the ~ of aqueous HCl. After 40 min the reaction mixture 
freezer overnight. Glassy needles formed and were was filtered and the precipitate washed with a total of 
filtered and washed with ethyl acetate to yield 3.0 g of 100 mL of warm water. Pale yellow crystals of product 
pure product (30%), m.p. 134"-135" C. melting at 230°-232° C. (dee.) were obtained from the 
N-[5-(N',N'-Dimethylcarbamoyl)hydroxy-1-methyl- 50 combined filtrate by both rotoevaporation and precipi-
2-pyridinemethylene] hydroxylamine chloride. Methyl tation with acetone. Yield 4.12 grams (95.3% ). lH NMR 
iodide (5.3 mL, 85 mmol) was added to a solution of (D20, TSP) 8: 8.45 (s, lH), 8.36 (d. lH, J=5.8 Hz), 8.03 
N-[5-(N',N' -dimethylcarbamoyl)hydroxy-2-pyridine (d, lH, J = 8.3 Hz), 7.80 (d of d. lH), 4.42 (s, Me). Anal. 
methylene] hydroxylamine (2.8 g, 13.4 mmol) in 25 mL Calcd for CsH11N4QiCl: C, 41.66; H, 4.81; N, 24.28; Cl, 
of acetonitrile. The resulting mixture was put into a 55 15.37. Found C, 41.59, H, 4.85; N, 24.28; Cl, 15.44. 
glass pr~ure vessel and heated at so· C. for 3 days. 2-[[(Aminothiocarbonyl)hydrazono]methyl]-3-
The solvent was removed in vacuo and the residue was hydroxy-I-methyl pyridinium chloride, 2-
dissolved in a minimum quantity of acetone, triturated hydrazonomethyl-3-hydroxy-1-methyl pyridinium 
with ether and placed in the freezer overnight. A dark chloride, 1-methyl-2-(3-hydroxy-1-methyl-2-
yellow solid resulted and was filtered under vacuum 60 pyridinemethylene) hydrazine chloride, I-methyl-l-
and washed with 1:1 ether/acetone to yield 3.25 g of the phenyl-2-(3-hydroxy-l-methyl-2-pyridinemethylene) 
iodide salt. Freshly made AgCl (2 eq, washed well with hydrazine chloride, l,l-diphenyl-2-(3-hydroxy-l-meth-
water) was added to the iodide salt in acetonitrile/water yl-2-pyridinemethylene) hydrazine chloride, 1-(2,4-dini-
(60 mL/100 mL) and stirred for several hours. After trophenyl)-2-(3-hydroxy-1-methyl-2-pyridinemethy-
filtration, the residue was crystallized from aceto- 65 lene) hydrazine chloride, and l-(2-naphtyl)-2-(3-
ne/ether and dried in the air for several days to yield 2.5 hydroxy-1-methyl-2-pyridinemethylene) hydrazine 
g of the chloride salt (monohydrate, 72% yield); m.p. chloride can be made by the same procedure replacing 
159°-160° C. 1H NMR (d6-DMSO) 8: 9.18 (s, lH); 8.65 semicarbazide in the above example respectively with 
5,206,371 
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thiosemicarbazide, hydrazine, methylhydrazine, 1- H, 5.26; N, 17.29; Cl, 10.94. Found: C, 51.90; H, 5.22; N, 
methyl-1-phenylhydrazine, 1,1-diphenylhydrazine, 2,4- 17.36; Cl, 10.89. 
dinitrophenylhydrazine, and 2-naphtylhydrazine. 2- 3-Hydroxy-l-methyl-2-[[(N-phenylaminothiocar-
[[(Aminocarbonyl)hydrazono ]methyl]-5-hydroxy-l- bonyl)hydrazono ]methyl] pyridinium chloride, 2-
methyl pyridinium chloride, 2-[[(aminothiocarbonyl)- s [[(N,N-diphenylaminocarbonyl)hydrazono]methyl]-3-
hydrazono]methyl]-5-hydroxy-l-methyl pyridinium hydroxy-1-methyl pyridinium chloride, 2-[[(N,N-dime-
chloride, 2-hydrazonomethyl-5-hydroxy-l-methyl pyri- thylaminothiocarbonyl)hydrazono ]methyl] 3-hydroxy-
dinium chloride, l-methyl-2-(5-hydroxy-l-methyl-2- 1-methyl pyridinium chloride, 2-[[(N-ethylaminothi-
pyridinemethylene) hydrazine chloride, l-methyl-1- ocarbonyl)hydrazono ]methyl]-3-hydroxy-l-methyl 
phenyl:2-(5-hy~oxy-l-m~thyl-2-pyridinemethylene) 10 pyridinium chloride, 3-hydroxy-l-methyl-2~[[(N-naph-
hydr~e. chlonde, l,l-diphen~l-2-(5-h~droxy-l-m~~- tylaminocarbonyl) hydrazono]methyl] pyridinium chlo-
yl-2-pyndinemethylene) hydrazine chlonde, 1-(2,4-dini- ride and 2-[[[N-(l-chloro-2-naphtyl)amino carbonyl]-trophenyl)-2~5-hydr'?xy-l-methyl-2-pyridinemethy- hychazono]methyl]-3-hydroxy-l-methyl pyridinium 
lene) hydraz~e. chlonde, and l-naph~yl-2-(5-hydroxy-l- chloride can be made by the same procedure replacing 
methyl-2-pyndinemethylene) hy~e chlonde can be IS 4-phenylsemicarbazide in the above example respec-
made by the same procedure replacmg 3-hydroxy-2- tively with 4-phenyl-3-thiosemicarbazide 4 4-diphenyl-
pyridine aldehyde with 2-formyl-5-hydroxy pyridine. semicarbazide, 4 4-dimethyl-3-thiosemi~bazide 4-
~-Hydrazo~omethyl-3-hydroxy-l,~ethyl pyridin- ethyl-3-thiosemicarl,azide, 4-(2-naphtyl)semicarb~de 
1um. .chlonde, l-methyl-2~1,6-dime~yl-3-hydroxy-2- and 4-(1-chloro-2-naphtyl)semicarbazide. 5-Hydroxy-1-
pyndinemethyl~ne) hydrazme chlond.e,. l-methyl-1- 20 methyl-2-[[(N-phenylaminocarbonyl)hydrazono] 
phenyl-2-(1,~ethyl-3_-hydroxy-2-pyn~emethy- methyl] pyridinium chloride, 5-hydroxy-l-methyl-2-
l~e) hydrazme chlond~ •. and l,l-diphenyl-2-(1.'6- [[(N-phenylaminothiocarbonyl) hydrazono]methyl] 
dimethyl-3-hydroxy-2-pyndinemethylene) hydrazme ·din· bl ·d 2 [[(N N ..:i: h 1amin bl ·d be mad b h 1 . pyn •um c on e, - , -uip eny ocar-c on e can e y t e same procedure rep acmg bo l)h dr ] th l] 5 h dr 1 th 1 · 3 h d 2 ·din aid h d · h bo 1 ny y azono me y - - y oxy- -me y pyn-
- y roxy- -pyn e e y e m t e a ve examp e 2s dini. bl ·d 2 [r.(N N-dim th 1amin thi bo 1) 
· h 3 h dr 6- h I 2 ·din aid h d um c on e, • L' • e Y 0 ocar ny 
wtt • Y oxy- met Y - -pyn e e Y e. h dr ] th l] 5 h d 1 h 1 ·dini· y azono me y - - y roxy- -met y pyn um 
EXAMPLE 11 chloride, 2-[[(N-ethylaminothiocarbonyl) hydrazono]-
Preparation of methyl]-5-hydroxy-l-methyl pyridinium chloride, 5-
3-Hydroxy-l-methyl-2-[[(N-phenylaminocarbonyl)hy- hydroxy-l-methyl-2-[[(N-naphtylaminocarbonyl)hy-
drazono ]methyl] pyridinium chloride (3b). 30 drazono]methyl] pyridinium chloride, and 2-[[[N-(l-
chloro-2-naphtyl)amino carbonyl]hydrazono]methyl]-
3-Hydroxy-2-[[(N-p~e~ylaminocarbonyl)h~- . 5-hydroxy-1-methyl pyridinium chloride can be made 
drazono]methyl] pyndme. 4-Phenyl semi~bazide by the same procedure replacing 3-hydroxy-2-pyridine 
(4.91 g, 33 mmol) was added to a suspension of 3- aldehyde with 2-formyl-5-hydroxy pyridine. 
hydroxy-2-pyridine carbaldehyde (4.0 g, 33 mmol) in a 3S 
mixture of ethanol water (30 mL:40 mL). The reaction EXAMPLE 12 
mixture was stirred at room temperature for 3 hand the Preparation of l-Methyl-2-[[(N-phenylaminocarbonyl) 
yellow product was collected by filtration. The yellow hydrazono]methyl] pyridinium chloride (3d) 
precipitate was washed with EtOH/H20 1: 1 and dried . 
under P20s to yield 8.22 g (99%) of product. It can be 40 2:[~(N-Phe~y~ammocarbonyl) hydrazono]methyl] 
recrystallized from EtOHJH20; m.p. 201•-2• C. (dee.). pyndine. Pyndine-2-Aldehyde (5.7 mL, 0.06 mol) was 
IH NMR (<16-DMSO) 8: 10.85 (br.s., lH); 10.6 (br.s., added to a suspension of sodium acetate (4.92 g, 0.06 
lH); 9.14 (s, lH); 8.27 (s, lH); 8.15 (d of d, lH); 7.55 {d, mol) and 4-phenyl semicarbazide (9.07 g, 0.06 mol) in 60 
2H); 7.26-7.36 (m, 4H); 7.01 (t, lH). mL of water. The resulting mixture was stirred at room 
3-Hydroxy-2-[[(N-phenylaminocarbonyl)hy- 4S temperature for T4 h and the solid in suspension was 
drazono]methyl]-1-methyl pyridinium chloride. Methyl filtered and washed thoroughly with water. After dry-
iodide (7.2 mL, 0.12 mol) was added to a suspension of ing, the semicarbazone was obtained as a dark beige 
2-[[(N-phenylaminocarbonyl)hydrazono]methyl]-3- solid (12.54 g, 87%) and was used in the next step with-
hydroxy pyridine (3. 72 g, 15 mmol) in 50 mL of acetoni- out further purification; m.p. 181° -182° C. 
trile. The reaction mixture was placed in two pressure so l-Methyl-2-[[(N-phenylaminocarbonyl) hydrazono]-
glass vessels and heated at 70" C. for 3 days. The solid methyl] pyridinium chloride. 2-[[(N-Phenylaminocar-
which filled the reaction flasks was filtered and tritu- bonyl) hydrazono]methyl] pyridine (4.47 g, 0.02 mol) 
rated well with warm (40° C.) acetone. The product was divided into two pressure glass tubes and dissolved 
was dried to yield 5.13 g (89%) ofmethiodide. It was in acetonitrile (20 mL each). Methyl iodide was then 
dissolved in a mixture of water/acetonitrile (500 SS added (2.6 mL each, 0.04 mol), the tubes were tightly 
mL:300 mL) and then freshly made AgCl (2 eq) was closed and heated at 65" C. for 3 days. The reaction 
added. The suspension was stirred at room temperature flasks were cooled to 10·-15• C. and the solid was fil-
for 2 h and then filtered through Celite. The filtrate was tered. The yellow solid was washed with acetone and 
concentrated to dryness in vacuo and the residue was ether and dried to yield 6.66 g (92%) of the iodide salt; 
triturated with acetone. The yellow solid was filtered, 60 m.p. 192°-193° C. {dee.). It was dissolved in 400 mL of 
washed with acetone and dried to yield 3.67 g (93%) of acetonitrile/water 1:1 and exchanged with freshly made 
the pure chloride; m.p. 220°-221• C. (dee.), It can be AgCl (from 5.92 g of AgN03 and excess cone. HCl, 
recrystallized frcim EtOH. IH NMR (<16-DMSO) 8: washed well with water). The resulting suspension was 
11.74 (br.s., lH); 9.27 (s, lH); 8.58 (d, lH, J =5.7 Hz); stirred at room temperature for 2 h. The silver iodide 
8.39 (s, lH); 8.17 {d, lH, J=8.2 Hz); 7.85 (d ofd, lH, 6S was filtered off and the filtrate was concentrated to 
J =5.7 Hz, J =8.2 Hz); 7.57 (d, 2H, J =7.6 Hz); 7.31 (t, dryness in vacuo to yield a yellow solid that was tritu-
2H, J=7.6 Hz); 7.04 (t, lH, J=7.6 Hz); 4.48 (s, 3H). rated with acetone and ether. It was filtered and dried 
Anal. Calcd. for C14li1sClN402X0.95 H20: C, 51.90; to yield 4.86 (96%) of the pure chloride salt as a yellow 
33 
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solid; m.p. 187°-188° C. (dee.). lH NMR (d6-DMSO) 8: 
11.87 {s, lH); 9.45 (s, lH); 8.98 (d of d, 2H); 8.56 (t, lH); 
8.43 (s, lH); 8.01 (t, lH); 7.62 (d, 2H); 7.34 (t, 2H); 7.08 
(t, lH); 4.36 (s, 3H). Anal. Calcd. for 
C14li1sClN40X0.48 H20: C, 56.15; H, 5.37; N, 18.7.1; S 
Cl, 11.84. Found: C, 56.15; H, 5.38; N, 18.69; Cl, 11.88. 
EXAMPLE 13 
Preparation of 
2-[[(Aminocarbonyl)hydrazono]methyl]-3-(N,N-dime- 10 
thylcarbamoyl)hydroxy-1-methyl pyridinium chloride 
(4a) 
34 
thylcarbamoyl)hydroxy-1-methyl pyridinium chloride 
can be made by the same procedure replacing 3-
hydroxy-2-pyridine aldehyde in the above example with 
2-formyl-5-hydroxy pyridine. 
EXAMPLE 14 
Preparation of 
3-(N,N-Dimethylcarbamoyl)hydroxy-1-methyl-2-[[(N-
phenylaminoc,arbonyl) hydrazono]methyl] pyridinium 
chloride ( 4b) 
3-(N,N-Dimethylcarbamoyl)hydroxy-2-[[(N-
phenylaminocarbonyl)hydrazono] methyl] pyridine 2~[~(Amin~nyl)hydrazono]methyl]-3-hydroxy_ was prepared by reaction of dimethylcarbamyl chloride 
pyndin~. Sodium acetate (2.21 g, 16 ~ol) v.:as dis- 15 (16 mL, 0.18 mol) with 3-hydroxy-2-[[(N-
solved m 25 mL of water and then semicarbazide by- phenylaminocarbonyl)hydrazono]methyl] pyridine (4.5 
drochloride was added (1.81 g, 16 mmol), followed by 
3-hydroxy-2-pyridine aldehyde (2.0 g, 16 mmol). The g, 17.5 mmol) in 30 mL of pyridine. The resulting mix-
ultin. g _;,....,. tirr" ed t tem tur ., 2 ture was stirred at room temperature for 6 h and poured res &.LUA .... e was s a room pera e •Or 500 mL f bed· · Th be' · · h. The solid in the reaction mixture was then filtered, over 0 crus ice. ~ ige precipita~ was 
washed with water and dried to yield 2.71 g (93%) of 20 C?llected, washed thoroughly with wate; and
0
dried to 
the semicarbazone. It was used in the next step without yield 5.48 g (95%) of product, m.p_. 178 -1~ C. Th_e 
further purification; m.p.: 215·-217• c. (dee.). p~oduct (5.48 g, 16.7 mmol) w~ ~lved m acetoru-
2-[[(Aminocarbonyl)hydrazono]methyl]-3-(N,N- trile/DMF and then methyl iodide (~.78 mL, 44.7 
dimethylcarbamoyl)hydroxy pyridine. The semicarba- mmol_X 3 vc:ssc=Is) was ad~ed to the ~eact10n vessel. The 
zone obtained in the previous step (2. 71 g, 15 mmol) was 25 resultm~ mixture ~as stirred at 70 . C. for 3 da~s. and 
suspended in 20 mL of pyridine and then N,N-dimethyl- cooled m a water-ice bath for 30 mm. The precipitate 
carbamyl chloride was added (4.2 mL, 45 mmol). The was collected by filtration, washed with acetone/ether 
reaction flask was sealed with a septum and the mixture 1:1 and dried to yield 6.42 g (82%) of the methiodide 
was stirred at room temperature for 20 h. The reaction salt. It was dissolved in 500 mL H20 and 300 mL aceto-
mixture becomes a clear solution after one hour and the 30 nitrile and then freshly made Agel (2 eq, washed well 
product begins to come out of solution after 2 h. When with water) was added. The resulting suspension was 
the reaction is complete, the mixture is cooled to 5° -10° stirred at room temperature for 2h. It was filtered 
C. in ice bath and filtered. The beige solid that results is through Celite and the filtrate was concentrated to 
washed with acetone/ether 1:1 and dried to yield 3.63 g dryness in vacuo to a crisp yellow foam that becomes a 
(96%) of the carbamate which is used in the next step 35 yellow solid after trituration with acetone. The yellow 
without further purification; m.p. 182°-3° C. (dee). solid was filtered, washed with ether and dried to yield 
2-[[(Aminoc_arbonyl)hydrazono]methyl]-3-(N,N- 4.83 g (93%) of pure product as the chloride salt; m.p. 
dimethylcarbamoyl)hydroxy-1-methyl pyridinium 176°-177" C. (dee.). Anal. Calcd. for 
chloride. The carbamate obtained in the previous step C 17H2()C1Ns03X0.84 H20: C, 51.95; H, 5.56; N, 17.82; 
(3.63 g, 14 mmol) was dissolved in 50 mL hot (90° C.) 40 Cl, 9.02. Found: C, 51.95; H, 5.55; N, 17.80; Cl, 9.11. 
DMF. When a clear solution was obtained, the reaction 5-(N,N-Dimethylcarbamoyl)hydroxy-l-methyl-2-
flask was cooled under running water until the inner [[(N-phenylaminocarbonyl) hydrazono]methyl] pyri-
temperature reached 26° C. Methyl ~odid7 (6.3 mL, 100 dinium chloride can be made by the same procedure 
mmo!) wa:' then added and the reaction Inl.Xture was left replacing 3-hydroxy-2-pyridine aldehyde with 2-for-
at 65 C. m a Parr shaker for 3 days. The solvent was 45 myl-5-hydroxy pyridine. 
removed in vacuo to yield a dark viscous residue which 
was triturated with acetone. The yellow solid that re-
sulted was washed with acetone/ether 1:1, then with 
ether and dried to yield 5.15 g (94%) of the methiodide. 
Freshly made AgCI (from 4.45 g AgN03 and excess so 
cone. HCI) was washed well with water and added to a 
EXAMPLE 15 
Preparation of 
2-(3-Hydroxy-1-methyl-2-pyridinemethylene)-1-(2-(1-
pyridinium)acetyl] hydrazine dichloride (5a) 
solution of the methiodide (5.15 g, 13 mmol) in 200 mL 2-(3-Hydroxy-2-pyridinemethylene)-1-[2-(1-pyridini-
.cctonitrile/water 1:1. The resulting suspension was um)acetyl] hydrazine chloride. 1-(Carboxymethyl) pyr-
stirred at room temperature for 1.5 h. The silver iodide idinium chloride hydrazide (2.63 g, 0.014 mol) in 10 mL 
was filtered through Celite and the filtrate was concen- SS of methanol was added to a solution of 2-aldehyde-3-
trated to dryness in vacuo to yield a residue which is hydroxy pyridine (1.72 g, 0.014 mol) in 20 mL of 
tritilrated with acetone. The resulting solid is filtered CH3CN. The resulting dark yellow solution is stirred at 
and recrystallized from CH3CN/EtOH and acetone to room temperature for 2 h and at the end of this period 
yield 2.44 g (62%) of the pure chloride salt; m.p. a beige solid filled the reaction mixture. Ethyl ether was 
194°-195° C. (dee.). Anal. Calcd. for 60 added (10 mL) and the reaction mixture was cooled to 
C11H16ClNsQ3X0.96 H20: C, 41.42; H, 5.66; N, 21.96; 5°-10° C. before filtering the beige precipitate. The 
Cl, 11.12. Found: C, 41.42; H, 5.72; N, 21.81; Cl, 11.20. solid was washed with ethyl ether and dried to yield 
2-[[(Aminocarbonyl)hydrazono]methyl]-3-(N,N- 3.72 g (91%) of product; m.p. 229°-30° C. (dee). 
dimethylcarbamoyl)hydroxy-1,6-dimethyl pyridinium 2-(3-Hydroxy-1-methyl-2-pyridinemethylene)-1-(2-
chloride can be made by the same procedure replacing 65 (1-pyridinium)acetyl] hydrazine dichloride. The acyl 
3-hydroxy-2-pyridine aldehyde in the above example hydrazone obtained in the previous step (3.5 g, 0.012 
with 3-hydroxy-6-methyl-2-pyridine aldehyde. 2- mol) was divided into three pressure glass vessels and 
[[(Aminocarbonyl)hydrazono]methyl]-5-(N,N-dime- each portion was dissolved in 20 mL of acetonitrile. 
35 
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Methyl iodide was added to these solutions (1.2 mL was stirred at room temperature for 2 h, with the prod-
each, 0.02 mol) and the resulting mixtures were heated uct beginning to come out of solution after 20 min of 
at 70° C. for 3 days. The reaction mixtures were concen- reaction. After 2 h the white solid in the reaction mix-
trated in vacuo to a dark residue which was triturated ture was filtered and washed with acetonitrile and 
with acetone/ethanol 5:1. The resulting yellow solid S ether. After drying, the product was obtained as a white 
was washed with acetone/ethanol 5:1 and dried to ob- solid (5.27 g, 68%) and was used in the next step with-
tain 4.39 g (84%) of the iodide salt, m.p. 193°-94° C. out further purification; m.p. 240°-241° C. (dee.). 'H 
(dee). Freshly made AgCI (from 3.43 g ~f AgN03 and NMR (d6-DMSO) 8: 12.43 (br.s., lH); 9.07 (d, 2H); 8.70 
excess cone. HCI) was washed well wtth water and (t, lH)· 8 66 (d lH)· 8 24 (d of d 2H)· 8 19 (s, lH)· 
~ded to a soluti~n .of the iodide salt (4.39 ~· 0.01 mol) 10 8.0l-7.9o (m, 2ir); 1.48~7.44 (m, 1Hr, 6.07 (s, 2H). ' 
~ 300 mL ~tomtrile/water 1:1. The resulting suspen- 2-(1-Methyl-2-pyridinemethylene)-1-[2-(1-pyridini-~o~ was stirred at room tempe~ture for 2 h. The silver um)acetyl] hydrazine dichloride. The acyl hydrazone 
iodide was filtered throu~h Celite and. the filtra~ was obtained in the revious ste (2.88 10 mmol) was 
concentrated to dryness m vacuo to yield a solid that . . . P P g, . 
was triturated with acetone. The dark beige solid was lS ~vided m~ two pressure vessels and .eac:h portion was 
filtered, washed with acetone and dried to yield 2.89 g dissolved m 2~ mL of DMF. Methyl iodide was added 
(84%) of pure product as the chloride salt; m.p. to th:SC ~lutions (1.62 mL each, ;5 mmol) and the 
230•-31• c. (dee.). Anal. Calcd. for resulting mixtures were heated at 70 C. for 3 days. The 
c 1..tt16c1iN4o 2xo.96 HiO· c 46.65· H 5.01· N 15.55· solvent was removed in vacuo to yield a dark residue 
Cl, 19.67. Found: C, 46.65; H.'4.95; N, i6.33;'c1: 20.66'. 20 which was triturated "?th acetone. The resulting ~lid 
2-(3-Hydroxy-1-methyl-2-pyridinemethylene)-l-[2- was filtered, washed wtth acetone and ether and dried 
(trimethylammonium)acetyl] hydrazine dichloride, 1- to yield 4.25 g (quantitative) of the methiodide as a 
[2-(4-chloro-1-pyridinium)acetyl]-2-(3-hydroxy-1-meth- yellow solid. Freshly made AgCl (from 3.77 g AgN03 
yl-2-pyridinemethylene) hydrazine dichloride, 1-[2-(3- and excess cone. HCl) was washed well with water and 
carboxy-1-isoquinolinium)acetyl]-2-(3-hydroxy-1-meth- 2s added to a solution of the iodide salt (4.18 g, 10 mmol) 
yl-2-pyridinemethylene) hydrazine dichloride, 1-[2-(2- in 200 mL acetonitrile/water 1:1. The resulting suspen-
carboxy-4-methoxy-l-quinolinium) acetyl]-2-(3- sion was stirred at room temperature for 1.5 h. The 
hydroxy-1-methyl-2-pyridinemethylene) hydrazine di- silver iodide was filtered through Celite and the filtrate 
chloride, 2-(3-hydroxy-l-methyl-2-pyridinemethylene)- was concentrated to dryness in vacuo to yield 3.63 g of 
1-[2-(3-hydroxy-l-pyridinium)acetyl) hydrazine dichlo- 30 a yellow solid. Recrystallization from ethanol/acetone 
ride, 2-(3-hydroxy-1-methyl-2-pyridinemethylene)-1-[2- affords the pure chloride as a beige solid (3.0 g, 92%); 
(1-methyl-1-piperidinium) acetyl] hydrazine dichloride m.p. 209° -210" C.(dec). IH NMR (d6-DMSO) 8: 9.13 (d, 
can be made by ~7 ~e pr~ure repla~ing 1-(car- 2H); 9.08 (d, lH); 8.75-8.59 (m, 4H); 8.26 (t, 2H); 8.10 
~xymet~yl) pyndimum chl~nde hydrazid~ respec- (m, lH); 6.19 (br.s., 2H); 4.42 (s, 3H). Anal. Calcd. for 
tively wtth (carboxymethyl)trimethylammomum chlo- 3S c 1..tt16ctiN4ox0.91 HiO: c 48.94· H 5.23· N 16.31· 
ride hydrazide (~!t'~d's reag7nt "T''), 4-chloro-1-(car- Cl, 20.64. Found: C, 48.94; H: 5.25; N, i6.3t;' CI'. 20.43'. 
boxymethyl)pyndimum chlonde hydrazide, 3-carboxy-
1-( carboxymethyl)isoquinolinium chloride hydrazide, EXAMPLE 17 
2-carboxy-4-methoxy-1-( carboxymethyl)quinolinium Preparation of 
chloride hydrazide, 3-hydroxy-1-(carboxymethyl)- 40 O-Diphenylmethyl-N-(3-hydroxy-1-methyl-2-
pyridinium chloride hydrazide, and 1-methyl-1-(carbox- pyridinemethylene) Hydroxylamine Iodide 
ymethyl) piperidinium chloride hydrazide. 2-(5-
Hydroxy-l-methyl-2-pyridinemethylene )-1-[2-(l- O-Diphenylmethyl-N-(3-hydroxy-2-pyridinemethy-
pyridinium)acetyl) hydrazine dichloride, 2-(5-hydroxy- lene) hydroxylamine. 0-Diphenyl methyl hydroxylam-
l-methyl-2-pyridinemethylene)-l-[2-(trimethylammoni- 4s ine hydrochloride (3.35 g, 14.2 mmol) was added to a 
um)acetyl] hydrazine dichloride, 1-[2-(4-chloro-1- solution ofNaOH (0.57 g, 14.2 mmol) in 10 mL ofH20. 
pyridinium)acetyl)-2-(5-hydroxy-1-methyl-2- After the addition of 10 mL of EtOH, 3-hydroxy-2-pyri-
pyridinemethylene) hydrazine dichloride, 1-[2-(3-car- dine aldehyde (1.75 g, 14.2 mmol) was added. The mix-
boxy-1-isoquinolinium)acetyl]-2-(5-hydroxy-1-methyl- ture was heated on a steam bath for 1 h. While the 
2-pyridinemethylene) hydrazine dichloride, 1-[2-(2-car- 50 solution was allowed to cool an additional 30 mL of boxy-4-methoxy-1-quinolinium)acetyl)2-(5-hydroxy-1- H20 was added. The product precipitated out as yellow 
methyl-2-pyridinemethylene) hydrazine dichloride, 2- needles. The mixture was filtered to isolate the pure 
(5-hydroxy-1-methyl-2-pyridinemethylene)-1-[2-(3- product (3.8 g, 89%), m.p. 83"-84° C. IH NMR 
hydroxy-1-pyridinium)acetyl) hydrazine dichloride, (CDCIJ) 8: 9.57 (s, lH); 8.40 (s, lH); 7.33 (s, lOH); 7.13 
and 2-(5-hydroxy-l-methyl-2-pyridinemethylene)-l-[2- SS (m, 3H); 6.23 (s, lH). Anal. Calcd. for C19H16N203: C, 
(1-piperidinium)acetyl) hydrazine dichloride can be 74.97; H, 5.31; N, 9.21. Found: C, 74.88; H, 5.32; N, 9.17. 
made by the same procedure replacing 3-hydroxy-2- O-Diphenylmethyl-N-(3-hydroxy-l-methyl-2-
pyridine aldehyde with 2-formyl-5-hydroxy pyridine. pyridinemethylene) hydroxylamine iodide. A solution 
EXAMPLE 16 of O-diphenylmethyl-N-(3-hydroxy-2-..pyridinemethy-
60 lene) hydroxylamine (1.0 g, 3.29 mmol) in 45 mL of 
Preparation of EtOH was placed in a glass pressure tube. Methyl io-
2-(1-Methyl-2-pyridinemethylene )- l-[2-(1-pyridinium- dide (0.9 mL, 13.8 mmol) was then added, and the tube 
)acetyl) hydrazine dichloride (Sb) was sealed tightly. The tube was heated at 69° C. in an 
2-(2-pyridinemethylene)-1-[2-(1-pyridinium)acetyl) oil bath for 20 h. The solvent was removed in vacuo, 
hydrazine chloride. 1-(Carboxymethyl) pyridinium 6S and the residue was triturated with acetone to give the 
chloride hydrazide (5.25 g, 28 mmol) and pyridine-2- product as a shiny dark yellow solid (1.4 g, 95%), m.p. 
carbaldehyde (2.7 mL, 28 mmol) were dissolved in 25 163°-165° C. The chloride salt can be obtained as de-
mL acetonitrile:methanol (4:1). The resulting mixture · scribed above. 
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EXAMPLE 18 hydroxy-2-pyridinemethylene) hydroxylamine chlo-
ride, 0-(2-hydroxy-4-nitrobenzyl)-N-(l,6-dimethyl-3-
Preparation of hydroxy-2-pyridinemethylene) hydroxylamine chlo-
O-Benzyl-N-(l,6-dimethyl-3-hydroxy-2-pyridinemethy- ride, O-(p-methoxybenzyl)-N-(l,6-dimethyl-3-hydroxy-
lene) Hydroxylamine Chloride 5 2-pyridinemethylene) hydroxylamine chloride, O-(p-
3-Hydroxy-6-methyl-2-pyridine carbaldehyde. 3- dimethyl aminocarbonyloxybenzyl)-N-(l,6-dimethyl-3-
Hydroxy-6-methyl-2-pyridine methanol (20.0 g, 0.14 hydroxy-2-pyridinemethylene) hydroxylamine chlo-
mol) and selenium dioxide(8.0 g, 72 mmol) were dis- ri~e, 0-(p-propylamin~bonyl bcnzyl)-N-(1,6-
solved in 140mLof1,4-dioxane and 280 mL of absolute dimethyl-3-hydroxy-2-pyndIDe methylene) hydroxy-
cthanol. The resulting mixture was heated at so• -85° c. 10 !amine chloride, 0-benzyl-N-[3-(N' ,N' -dimethylcar-
for 12 h. The selenium precipitate was removed by bamoyl)hydroxy-1,6-dimethyl-2-pyridinemethylene] 
filtration and the filtrate was concentrated to dryness in hydroxylamine chloride, 0-benzyl-N-[3-(N' ,N'-diethyl-
vacuo. The dark red residue was sublimed at 90• C. and carbamoyl)hydroxy-1,6-dimethyl-2-pyridinemethylene] 
14 mmHg for 6 h to obtain 11.0 g (56%) of pure prod- hydroxylamine chloride, 0-benzyl-N-[3-(N',N'-
uct, m.p. 101·-102• C.; 1H NMR (CDCh) 8: 10.50 (br s, 15 difluorocthylcarbamoyl)hydroxy-1,6-dimethyl-2-
lH), 10.03 (s, lH), 7.27 (s, 2H); 2.53 (s, 3H). pyridinemethylene] hydroxylamine chloride, O-(di-
0-Bcnzyl-N-(3-hydroxy-6-methyl-2-pyridinemethy- phenylmethyl)-N-(3-(N',N'-dimethylcarbamoyl)hy-
lene) hydroxylamine. Sodium hydroxide (3.2 g, 0.08 droxy-1,6-dimethyl-2-pyridinemethylene] hydroxylam-
mol) was dissolved in 80 mL of a 1:1 mixture of ine chloride, 0-(diphenylmethyl)-N-[l,6-dimcthyl- 3-
cthanol/water and then 0-Benzylhydroxylamine hy- 20 (N'-isopropylcarbamoyl)hydroxy-2pyridinemethylene] 
drochloride (12.77 g, 0.08 mol) was added. The reaction hydroxylamine chloride, 0-(diphenylmethyl)-N-[3-(N'-
mixture was stirred at room temperature and when a (2-fluorocthyl)carbamoyl]hydroxy-1,6-dimethyl-2-
clear solution was obtained 11.0 g (0.08 mol) of 3- pyridin-:methylene] hydroxylamine chloride, O-(p-
hydroxy-6-methyl-2-pyridine carbaldehyde was added methoxybenzyl)-N-[3-(N',N'-dimethylcarbamoyl)hy-
and the resulting mixture was stirred at room tempera- 25 droxy-1,6-dimethyl-2-pyridinemethylene] hydroxylam-
ture for 11 h. The reaction mixture was cooled in an ice ine chloride, 0-(p-methoxybenzyl)-N-[3-(N',N'-dime-
bath and filtered to yield 18.S3 g (96%) of product as a thylcarbamoyl)hydroxy-1-ethyl-6-methyl-2-
white solid, m.p. 81°-82° C. 1H NMR (MeiS0-<16) 8: pyridinemethylene] hydroxylamine chloride, O-(p-
9.85 (br s, lH), 8.40 (s, lH), 7.30-7.47 (m, SH), 7.22 (d, methoxybenzyl)-N-(3-(N',N'-dimethylcarbamoyl)hy-
lH), 7.13 (d, lH), s.~2 (s, 2H), 2.36 (s, 3H). 30 droxy-l-benzyl-6-methyl-2-pyridinemethylene] hydrox-
~-~nzyl-N-(l,6-dimethyl-3-h~dro~y-~- ylamine bromide, N-[3-(N',N'-dimethylcarbamoyl)hy-
pyndinemethylene) hydroxylamine 1od1de. 0-Bcnzyl- droxy-1 6-dimethyl-2-pyridinemethylene] bydroxylam-N-(~-hydroxy-6-methyl-2-pyridin~ethyle?e) hydroxy- ine ' chloride, l,6-dimethyl-3-hydroxy-2-[[(N-
lamine. (~0.0 g, 0.04 mol) was dissolved ID. 7~ mL of phenylaminocarbonyl)hydrazono] methyl] pyridinium 
aceto.rutril~ and 7. 7 mL (0.12 ~ol) of methyl iodide. The 3S chloride, 1,6-dimethyl-3-hydroxy-2-[[(N-phenylamino-
r~tion mixture was heated ID a pressure glass.vessel at thiocarbonyl) hydrazono]methyl] pyridinium chloride, 
90 C. for ~ days. Th~ solvent ~as removed ID. vacuo 1,6-Dimethyl-2-[[(N,N-diphenylaminocarbonyl) hy-
and the residue ~as tnturated ~t~ acetone to yield 8.1 drazono]methyl]-3-hydroxy pyridinium chloride, 2-
g of a yello~ solid. Recrystallization from acctone/E- (l,6-dimethyl-3-hydroxy-2-pyridinemethylene)-1-[2-(1-
tOH/Et2~ yi~lds S.S g (3S%) of pure. product as~ pale 40 pyridinium)acctyl] hydrazine dichloride, 2-(1,6-dimeth-
yellow sohd, H NMR (Me2SO-d6) 8. 8.SS (s, lH), 7.92 yl-3-hydroxy-2-pyridinemethylene)-1-[2-(trimethylam-
(d, lH); 7.87 (d, lH); 7.30-7.48 (m, SH); S.2,5.33 (s, 2H); monium)acctyl] hydrazine dichloride, and 2-(1,6-
3.93,4.08 (s, 3H); 2.7~ (s, 3H). dimethyl-3-hydroxy-2-pyridinemethylene)-1-[2-(4-
~-~nzyl-N-(l,6-dtmethyl-3-h.ydroxy-~- chloro-1-pyridinium)acctyl] hydrazine dichloride can 
pyndine~ethylene) hydroxyl~e.chlonde. 0-Bcnzyl- 45 be made by the same procedure replacing 3-hydroxy-2-
N-(l,6-dimethyl-3-hydroxy-2-pyndinemethylene) by- "din bald h d ·th 3 h cir 1:. th 1 2 · 
1 · "od"d ( . 1 . pyn e car e y e wt - y oxy-v-me y - -pyn-droxy amme i 1 e S.S g, 14 mmol) were disso ved ID din carbald h d 
700 mL of water and 4.1 g (28 mmol) of freshly pre- e e Y e. 
pared AgCl (from silver nitrate and excess cone. HCl) EXAMPLE 19 
was then added. The suspension was stirred mechani- so 
cally for 2.5 h at room temperature and the silver iodide 
was then removed by filtration. The filtrate was con-
centrated to dryness in vacuo and the residue was tritu-
Preparation of 
0-Benzyl-N-(l-benzyl-3-hydroxy-2-pyridinemethy-
lene) hydroxylamine bromide 
rated with acetone to yield 3.6 g (86%) of pure product O-Bcnzyl-N-(3-hydroxy-2-pyridinemethylene) hy-
as a light beige solid, m.p. 175°-6° C. (dee.). IH NMR SS droxylamine. 0-Bcnzyl hydroxylamine (10.4 g, 65 
(MeiSO-d6) 8: 8.52, 8.06 (s, lH); 8.10 (d, lH); 7.8S (t, mmol) was added to a solution of NaOH (2.6 g, 6S 
lH); 7.30-7.45 (m, SH); S.30, S.20 (s, 2H); 4.1, 3.9 (s, mmol) in 66 mL ofH20/EtOH 1:1. 3-Hydroxy-2-pyri-
3H); 2.69 (s, 3H). Anal. Calcd. for C1sHr1ClN202XO.lS dine carbaldehyde (8.0 g, 65 mmol) was added to this 
H20: C, 60.96; H, S.90; N, 9.48; Cl, 12.00. Found: C, solution and the resulting mixture was stirred at room 
60.96; H, S.90; N, 9.Sl; Cl, 12.02. 60 temperature 3 h. The white precipitate was then filtered 
0-(1-Naphtyqnethyl)-N-(1,6-dimethyl-3-hydroxy-2- and dried to yield 13.3 g (90%) of pure product, m.p. 
pyridinemethylene) hydroxylamine chloride, 0-(2- 64°-6S° C. lH NMR (CDCh) 8: 9.72 (s, lH); 8.37 (s, 
methyl-l-naphtylmethyl)-N-(l,6-dimethyl-3-hydroxy- lH); 8.13 (d of d, J =2 Hz, J =4 Hz, lH); 7.33 (m, 7H); 
2-pyridinemethylene) hydroxylamine chloride, 0-meth- S.17 (s, 2H). 
yl-N-(l,6-dimethyl-3-hydroxy-2-pyridinemethylene) 6S O-Benzyl-N-(l-benzyl-3-hydroxy-2-pyridinemethy-
hydroxylamine chloride, 0-(p-chlorobenzyl)-N-(l,6- Jene) hydroxylamine bromide. Bcnzyl bromide (0.78 
dimethyl-3-hydroxy-2-pyridinemethylene) hydroxy- m.L, 6.6 mmol) was added to a solution of 0-benzyl-N-
lamine chloride, 0-(p-cyanobenzyl)-N-(l,6-dimethyl-3- (3-hydroxy-2-pyridine methylene) hydroxylamine (1.0 
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g, 4.4 mmol) in 4 mL of acetonitrile. The resulting mix-
ture was heated at 65° C. in a pressure bottle for 3 days. 
The solvent was removed in vacuo and coevaporated 
with water to leave an oily residue that was dissolved in 
100 mL of water and treated with activated charcoal. 
This mixture was filtered through Celite and the filtrate 
was concentrated to dryness under high vacuum. Ace-
tone (20 mL) was added to the residue and the product 
crystallized as light beige needles (1.5 g, 86%), m.p. 
145°-146° C. lff NMR (CDClJ) 8: 8.68 (s, lH); 8.63 (d 
of d, lH); 8.52 (t, lH); 7.69 (d of d, 1H); 7.35 (m, 8H); 
7.10 (m, 2H); 6.12 (s, 2H); 5.25 (s, 2H). Anal. Calcd. for 
C2Qli19BrN202: C, 60.16; H, 4.80; N, 7.02; Br, 20.02. 
Found: C, 59.89; H, 4.86; N, 7.00; Br, 19.91. 
O-Benzyl-N-(l-benzyl-5-hydroxy-2-pyridinemethy-
lene) hydroxylamine bromide can be made by the same 
procedure replacing 3-hydroxy-2-pyridine aldehyde in 
the above example with 2-formyl-5-hydroxy pyridine. 
TABLE I 
Kinetic Constants for the Reversible Inhibition of Electric 
Eel and Human Erythrocyte Acetylcholinesterase. 
K1(eel) K1(human) ICso (eel) ICso (human) 
compd · p.M p.M p.M p.M 
la 40 100 100 17S 
lb 500 >600 
le 
ld 
le 
If 
3a 
3b 
4b 
Sa 
Sb 
30, J4()b 
85 
10 
c 
100 
20 
c 
NJO NJO 
400 >500 
400 >500 
NJO NJO 
32S 300 
240 
40 40 
~ DO inlubition at concentrations up to I mM. 
'Two diltinct K/s with eel AChE, multiple binding with both enzymes. 
'Multiple binding oboerved, only ICso values determined. 
TABLE II 
Kinetic Costants for the Irreversible Inhibition of Electric 
Eel and Human Ery!hrocyte Acetylcholinesterase. 
com pd 
2a 
2b 
2c 
4a 
~ 
1700 68000 NT" 
870 1100 NT" 
sooo > 110000 NT" 
25 2200 100 
ssoc 13000 NT" 
14000' 19000 NT" 
"NT, not tested (mlul>itioo half.life is too short to measure occmately); 
~e; 
 = 843 M-1,-1 (Forsberg, A. llDd Puu, G., Eur. J. Biocbem. 1914, 140, 
5 
10 
15 
20 
25 
30 
TABLE III-continued 
In Vivo Evaluation of Pyridinium Derivatives as 
Intramuscular Pretreatment Agents Against GD in Mice. 
LDso timeO doseb 
com pd (!Lmol/kg) (min) (!Lmol/kg) % survival 
2d 600 lS/60 9.0 90/90 
37 90no 
ISO SO/O 
3b >40 lS/60 1.3/S.2 0/20 
3c >S60 lS/60 0.017-0.28 40-70/30-40 
3d >430 lS/60 0.013-0.21S 20-40/10-30 
4a >1240 lS/60 0.2 S0/9Cl 
0.6 80/100 
2.3 80/80 
4b 42 IS 0.6S 90 
2.7 90 
11 40 
4b 60 0.65-11 70-80 
Sa >670 lS/60 18-290 70-100/20-70 
Sb 380 lS/60 0.6 40/20 
24 100/30 
96 100/100 
~ were tested at two different time intervals to allow for differences in 
biolvailability; 
6Tbree different dOlel were tested, only one dooe is recorded for inactive com· 
pounds. 
com pd 
lb 
le 
2a 
2b 
TABLE IV 
In Vivo Evaluation of Pyridinium Derivatives as Oral 
Pretreatment Agents Against GD in Mice. 
LDso time" doseb 
(µmol/kg) (min) (!Lmol/kg) % survival 
3600 30/120 60 
>3200 30/120 200 
220 30/120 3.4 
490 30/120 120 
2c 
35 4b 
Sa 
140 30/120 2.2 
670 30/120 10 
2900 30/120 730 
30no 
O/SO 
90/80 
90/100 
100/100 
70/100 
40/SO 
40 
45 
~pounds were tested at two different time intervals to allow for differences in 
biolvailability; 
6Tbree different dOlel were tested, only one dooe is recorded for inactive com-
pounds. 
TABLEV 
In Vivo Evaluation of Pyridinium Derivatives as 
Reactivators Against GD in Mice. 
LDso dose" 
compd (!Lmol/kg) (!Lmol/kg) % survival 
la 180 2.8 20 
lb >880 S.6 20 
Id >320 40 20 
le >760 20 0 
~ so ~yoootipine; If >610 12 0 
"k.WtIJ ~ llSOO M-1,-1 (Fonberg, A. llDd Puu, G, Eur. J. Biocbem. 1984, 140, 
JU). 
TABLE III 
~~~~~~~~~~~~~~~~~~~~55 
In Vivo Evaluation of Pyridinium Derivatives as 
Intramuscular Pretreatment Agents Apinst GD in Mice. 
LDso time" dose'> 
compd (!Lmol/kg) (min) (µmol/kg) % survival 
la 180 lS/60 3.0-4S 10-20 
lb >880 lS/60 22 0/10 (j() 
ld >320 lS/60 9.6 10/20 
le >760 lS/60 320/81 40/10 
If >610 lS/60 310n1 30/20 
lg >Sl4 lS/60 16/260 10/20 
2a o.s lS/60 0.009-0.14 80-90 
2b 22 IS 0.30 90 65 
1.4 60 
S.4 30 
60 0.30-S.4 60-70 
2c 84 lS/60 0.005-0.11 50-70 
lg >Sl4 IS 0 
2a 0.5 0.009-0.14 30-SO 
2b 22 0.33 20 
1.4 70 
S.4 60 
2c 84 1.3 20 
3a >1100 21b so 
11<>6 70 
4306 90 
6.8 20 
54 0 
430 70 
3b >40 1.3 10 
3c >560 0.28 10 
3d >430 0.215 20 
4a 9.6 0.2-2.3 0-SO 
4b 42 0.6S-11 30-SO 
Sa >670 lS-290 70-90 
Sb 380 6 20 
24 40 
96 90 
2-PAMCI 853 S3 0 
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TABLE V-continued 
In Vivo Evaluation of Pyridinium Derivatives as 
Rcactivators Against GD in Mice. 
com pd 
LD30 
(µ.mol!kg) 
dose" 
(p.mol/kg) % survival 
lil-6 4500 280-1125 90-100 
s 
42 
-continued 
"I'bree different c1ooes were -..i, only ,_ dole ii recorded for imctive com- with any counterion to make pharmaceutically accept-
poada; - 10 able salts, wherein -
6-ljunct emc.cy-. oee text foe details. Z is selected from the group consisting of C1-6 alkyl, 
TABLE VI 
In Vivo Evaluation of Pyridinium Derivatives as 
compd 
le 
If 
lg 
2a 
2c 
4a 
4b 
Sa 
Sb 
Rcactivators Against GA in Mice. 
LD30 
(p.mol/kg) 
>1970 
2100 
>SIO 
o.s 
84 
9.6 
670 
>670 
380 
dose 
(p.mol/kg) 
30 
33 
16 
0.009 
o.oos 
0.60 
2.70 
18 
73 
290 
6 
24 
96 
% survival0 
0 
0 
0 
30 
20 
20 
30 
10 
80 
90 
10 
0 
80 
'"Th= different dooes were -..!, only one dole ii recorded for in.lctive com-
pounds. 
What is claimed is: 
1. A compound of the group consisting of the formu-
las: 
and 
lS 
C1-6 alkyl with an attached phenyl group, C1-6 
alkyl with an attached naphtyl group, C1-6 alkyl 
with two attached phenyl groups, C1-6 alkyl with 
an attached phenyl group mono, di, or trisubstitu-
ted with J, C1-6 alkyl with two attached phenyl 
groups mono, di, or trisubstituted with J, C1-6 alkyl 
with an attached naphtyl group mono, di, or trisub-
stituted with J, 
20 wherein J is selected from the group consisting of 
2S. 
30 
3S 
40 
45 
so 
SS 
60 
65 
halogen, COOH, OH, CN, NC>i, NH2, C1-6 alkyl, 
Ct-6 alkoxy, C1-6 alkylamine, C1-6 al-
kyl-O-CO-,C1-6 alkyl-O-CO-NH-C1-6 
alkyl-NH-CO-NH-, C1-6 alkyl-N-
H-CO-NH-, C1-6 alkyl-NH-C0--0, C1-6 
alkyl NH-CO-(C1-6 alkyl)2N-CO-, wherein 
X is selected from the group consisting of OH, 
C1-6 alkyl-NH-CO--O-, (C1-6 alkyl)-
2-N-CO--O-, C1-6 fluoroalkyl-N-
H-C0--0, (C1-6fiuoroalkyl)2-NH-CO--O-, 
Rs is selected from the group consisting of C1-6 alkyl, 
phenyl, Ct-6 alkyl with an attached phenyl group, 
Ct-6alkyl with an attached phenyl group mono, di, 
or trisubstituted with K, Ct-6 alkyl with an at-
tached naphthyl group, Ct-6 alkyl with an attached 
naphthyl group mono, di, or trisubstituted with K, 
wherein Rt; is selected from the group consisting of 
H, Ct-6 alkyl, phenyl, Ct-6 alkyl with an attached 
phenyl group, Ct-6 alkyl with an attached phenyl 
group mono, di, or trisubstituted with K 
wherein K is selected from the group consisting of 
halogen, COOH, OH, CN, N02, NH2, Ct-6 al-
kyl-, Ct-6 alkoxy, C1-6 alkylamine, Ct-6 al-
kyl-0-CO-, Ct-6 0-CO-NH-, (Ct-6 al-
kyl-NH-CO-NH, Ct-6 alkyl-N-
H-C0--0-, Ct-6 alkyl NH-CO, (Ct-6 alkyl)-
2N-CO-, 
wherein B is selected from the group consisting of 
H,Ct-6 alkyl. 
• • • • • 
